Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy   |   
enzyme (lysozyme)

 
Enzymes
  Enzyme classes:
  EC 1: Oxidoreductases
  EC 2: Transferases
    EC 2.1
    EC 2.2
    EC 2.3
    EC 2.4
    EC 2.5
    EC 2.6
    EC 2.7
      EC 2.7.1
      EC 2.7.2
      EC 2.7.3
      EC 2.7.4
      EC 2.7.5
      EC 2.7.6
      EC 2.7.7
      EC 2.7.8
      EC 2.7.9
      EC 2.7.10
      EC 2.7.11
        EC 2.7.11.1
        EC 2.7.11.2
        EC 2.7.11.3
        EC 2.7.11.4
        EC 2.7.11.6
        EC 2.7.11.7
        EC 2.7.11.8
        EC 2.7.11.9
        EC 2.7.11.10
        EC 2.7.11.11
        EC 2.7.11.12
        EC 2.7.11.13
        EC 2.7.11.14
        EC 2.7.11.15
        EC 2.7.11.16
        EC 2.7.11.17
        EC 2.7.11.18
        EC 2.7.11.19
        EC 2.7.11.20
        EC 2.7.11.21
        EC 2.7.11.22
        EC 2.7.11.23
        EC 2.7.11.24
        EC 2.7.11.25
        EC 2.7.11.26
        EC 2.7.11.27
        EC 2.7.11.28
        EC 2.7.11.29
        EC 2.7.11.30
        EC 2.7.11.31
      EC 2.7.12
      EC 2.7.13
      EC 2.7.14
    EC 2.8
    EC 2.9
  EC 3: Hydrolases
  EC 4: Lyases
  EC 5: Isomerases
  EC 6: Ligases
  General information:
  Catalytic mechanism
  Enzyme kinetics
  Inhibitors
  Enzymes in industry

EC 2.7.11.1 - ATP:protein phosphotransferase (non- specific) (non- specific serine/threonine protein kinase)



3D structures of EC 2.7.11.1 - non-specific serine/threonine protein kinase in Protein Data Bank

updated: 29 May 2015, 1:12

In total: 1200 PDB structures of EC 2.7.11.1 - non-specific serine/threonine protein kinase:
  1. 3p1a: Structure of Human Membrane-associated Tyrosine- and Threonine- Specific Cdc2-inhibitory Kinase Myt1 (pkmyt1)
  2. 3ow4: Discovery of Dihydrothieno- and Dihydrofuropyrimidines as Potent Pan Akt Inhibitors
  3. 3ot8: X-ray Crystal Structure of Compound 17r Bound to Human Chk1 Kinase Domain
  4. 3ot3: X-ray Crystal Structure of Compound 22k Bound to Human Chk1 Kinase Domain
  5. 3op5: Human Vaccinia-related Kinase 1
  6. 3omv: Crystal Structure of C-raf (raf-1)
  7. 3og7: B-raf Kinase V600E Oncogenic Mutant in Complex with Plx4032
  8. 3o96: Crystal Structure of Human Akt1 with an Allosteric Inhibitor
  9. 3o51: Crystal Structure of Anthranilamide 10 Bound to Auroraa
  10. 3o50: Crystal Structure of Benzamide 9 Bound to Auroraa
  11. 3ny5: Crystal Structure of The Rbd Domain of Serine/threonine-protein Kinase B-raf from Homo Sapiens. Northeast Structural Genomics Consortium Target HR4694F
  12. 3nrm: Imidazo[1,2-a]pyrazine-based Aurora Kinase Inhibitors
  13. 3nkx: Impaired Binding of 14-3-3 to Raf1 Is Linked to Noonan and Leopard Syndrome
  14. 3nay: Pdk1 in Complex with Inhibitor Mp6
  15. 3nax: Pdk1 in Complex with Inhibitor Mp7
  16. 3myg: Aurora a Kinase Complexed with Sch 1473759
  17. 3mvh: Crystal Structure of Akt-1-inhibitor Complexes
  18. 3mv5: Crystal Structure of Akt-1-inhibitor Complexes
  19. 3mop: The Ternary Death Domain Complex of Myd88, Irak4, and Irak2
  20. 3mn3: An Inhibited Conformation for The Protein Kinase Domain of The Saccharomyces Cerevisiae Ampk Homolog Snf1
  21. 1mry: Crystal Structure of an Inactive Akt2 Kinase Domain
  22. 3mfu: Cask-4m Cam Kinase Domain, Amppnp-mn2+
  23. 3mft: Cask-4m Cam Kinase Domain, Mn2+
  24. 3mfs: Cask-4m Cam Kinase Domain, Amppnp
  25. 3mfr: Cask-4m Cam Kinase Domain, Native
  26. 3mb7: Human Ck2 Catalytic Domain in Complex with a Difurane Derivative Inhibitor (amr)
  27. 3mb6: Human Ck2 Catalytic Domain in Complex with a Difurane Derivative Inhibitor (cpa)
  28. 3ma3: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Naphtho-difuran Ligand
  29. 3m9g: Crystal Structure of The Three-pasta-domain of a Ser/thr Kinase from Staphylococcus Aureus
  30. 3m2w: Crystal Structure of Mapkak Kinase 2 (mk2) Complexed with a Spiroazetidine-tetracyclic Atp Site Inhibitor
  31. 3lm5: Crystal Structure of Human Serine/threonine Kinase 17b (STK17B) in Complex with Quercetin
  32. 3lm0: Crystal Structure of Human Serine/threonine Kinase 17b (STK17B)
  33. 3ll6: Crystal Structure of The Human Cyclin G Associated Kinase (gak)
  34. 3lj2: Ire1 Complexed with Jak Inhibitor I
  35. 3lj1: Ire1 Complexed with Cdk1/2 Inhibitor III
  36. 3lj0: Ire1 Complexed with Adp and Quercetin
  37. 3lau: Crystal Structure of Aurora2 Kinase in Complex with a GSK3BETA Inhibitor
  38. 3kxn: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor Tetraiodobenzimidazole (k88)
  39. 3kxm: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor K74
  40. 3kxj: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor 4,5,6,7-tetrabromo-1-carboxymethylbenzimidazole (k68)
  41. 3kxh: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor (2-dymethylammino-4,5,6,7-tetrabromobenzoimidazol-1yl- Acetic Acid (k66)
  42. 3kxg: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor 3,4,5,6,7-pentabromo-1h-indazole (k64)
  43. 3kud: Complex of Ras-gdp with RAFRBD(A85K)
  44. 3kuc: Complex of RAP1A(E30D/K31E)GDP with RAFRBD(A85K/N71R)
  45. 3knb: Crystal Structure of The Titin C-terminus in Complex with Obscurin- like 1
  46. 3kn6: Crystal Structure of The C-terminal Kinase Domain of Msk1
  47. 3kn5: Crystal Structure of The C-terminal Kinase Domain of Msk1 in Complex with Amp-pnp
  48. 3khf: The Crystal Structure of The Pdz Domain of Human Microtubule Associated Serine/threonine Kinase 3 (mast3)
  49. 3kgv: Crystal Structure of Human Dna-dependent Protein Kinase Catalytic Subunit (dna-pkcs)
  50. 3kga: Crystal Structure of Mapkap Kinase 2 (mk2) Complexed with a Potent 3-aminopyrazole Atp Site Inhibitor
  51. 3kc3: Mk2 Complexed to Inhibitor N4-(7-(benzofuran-2-yl)-1h-indazol-5-yl) Pyrimidine-2,4-diamine
  52. 3ka0: Mk2 Complex with Inhibitor 6-(5-(2-aminopyrimidin-4-ylamino)-2- Hydroxyphenyl)-n-methylbenzo[b]thiophene-2-carboxamide
  53. 3k5u: Identification, Sar Studies and X-ray Cocrystal Analysis of a Novel Furano-pyrimidine Aurora Kinase a Inhibitor
  54. 3k21: Crystal Structure of Carboxy-terminus of PFC0420W.
  55. 3k0e: Crystal Structure of The Phosphorylation-site Mutant T426N of The Kaic Circadian Clock Protein
  56. 3k0c: Crystal Structure of The Phosphorylation-site Double Mutant S431A/T432E of The Kaic Circadian Clock Protein
  57. 3k0a: Crystal Structure of The Phosphorylation-site Mutant S431A of The Kaic Circadian Clock Protein
  58. 3k09: Crystal Structure of The Phosphorylation-site Mutant S431D of The Kaic Circadian Clock Protein
  59. 3jzm: Crystal Structure of The Phosphorylation-site Mutant T432A of The Kaic Circadian Clock Protein
  60. 3jya: Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective and Orally Bioavailable Pim Kinases Inhibitors
  61. 3jy0: Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective and Orally Bioavailable Pim Kinases Inhibitors
  62. 3jxw: Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective and Orally Bioavailable Pim Kinases Inhibitors
  63. 3jvs: Characterization of The Chk1 Allosteric Inhibitor Binding Site
  64. 3jvr: Characterization of The Chk1 Allosteric Inhibitor Binding Site
  65. 3juh: Crystal Structure of a Mutant of Human Protein Kinase CK2ALPHA with Altered Cosubstrate Specificity
  66. 3jpv: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Pyrrolo[2,3-a]carbazole Ligand
  67. 3ixe: Structural Basis of Competition between Pinch1 and Pinch2 for Binding to The Ankyrin Repeat Domain of Integrin-linked Kinase
  68. 3iq7: Crystal Structure of Human Haspin in Complex with 5-iodotubercidin
  69. 3iop: Pdk-1 in Complex with The Inhibitor Compound-8i
  70. 3ion: Pdk1 in Complex with Compound 8h
  71. 3ii5: The Complex of Wild-type B-raf with Pyrazolo Pyrimidine Inhibitor
  72. 3iec: Helicobacter Pylori Caga Inhibits Par1/mark Family Kinases by Mimicking Host Substrates
  73. 3idp: B-raf V600E Kinase Domain in Complex with an Aminoisoquinoline Inhibitor
  74. 3i6w: Structure and Activation Mechanism of The Chk2 Dna-damage Checkpoint Kinase
  75. 3i6u: Structure and Activation Mechanism of The Chk2 Dna-damage Checkpoint Kinase
  76. 3hyh: Crystal Structure of The Protein Kinase Domain of Yeast Amp- Activated Protein Kinase Snf1
  77. 3hrc: Crystal Structure of a Mutant of Human Pdk1 Kinase Domain in Complex with Atp
  78. 3hdn: Crystal Structure of Serum and Glucocorticoid-regulated Kinase 1 in Complex with Compound 2
  79. 3hdm: Crystal Structure of Serum and Glucocorticoid-regulated Kinase 1 in Complex with Compound 1
  80. 3ha6: Crystal Structure of Aurora a in Complex with Tpx2 and Compound 10
  81. 3h9o: Phosphoinositide-dependent Protein Kinase 1 (pdk-1) in Complex with Compound 9
  82. 3h4j: Crystal Structure of Pombe Ampk Kdaid Fragment
  83. 3h30: Crystal Structure of The Catalytic Subunit of Human Protein Kinase Ck2 with 5,6-dichloro-1-beta-d- Ribofuranosylbenzimidazole
  84. 3h10: Aurora a Inhibitor Complex
  85. 3h0z: Aurora a in Complex with a Bisanilinopyrimidine
  86. 3h0y: Aurora a in Complex with a Bisanilinopyrimidine
  87. 3gub: Crystal Structure of DAPKL93G Complexed with N6-(2- Phenylethyl)adenosine
  88. 3gu8: Crystal Structure of DAPKL93G with N6-cyclopentyladenosine
  89. 3gu7: Crystal Structure of DAPKQ23V-ADP-MG2+
  90. 3gu6: Crystal Structure of DAPKQ23V-ADP
  91. 3gu5: Crystal Structure of DAPKQ23V-AMPPNP-MG2+
  92. 3gu4: Crystal Structure of DAPKQ23V-AMPPNP
  93. 3gre: Crystal Structure of Saccharomyces Cerevisiae Vps15 Wd Repeat Domain
  94. 3gok: Binding Site Mapping of Protein Ligands
  95. 3ggf: Crystal Structure of Human Serine/threonine-protein Kinase Mst4 in Complex with an Quinazolin
  96. 3g51: Structural Diversity of The Active Conformation of The N- Terminal Kinase Domain of P90 Ribosomal S6 Kinase 2
  97. 3fyk: Crystal Structure of a Benzthiophene Lead Bound to Mapkap Kinase-2 (mk-2)
  98. 3fyj: Crystal Structure of an Optimzied Benzothiophene Inhibitor Bound to Mapkap Kinase-2 (mk-2)
  99. 3fy0: Crystal Structure of Pak1 Kinase Domain with Ruthenium Complex Dw1
  100. 3fxz: Crystal Structure of Pak1 Kinase Domain with Ruthenium Complex Lambda-fl172
  101. 3fxw: High Resolution Crystal Structure of Mitogen-activated Protein Kinase-activated Protein Kinase 3/inhibitor 2 Complex
  102. 3fwq: Inactive Conformation of Human Protein Kinase Ck2 Catalytic Subunit
  103. 3fpq: Crystal Structure of The Kinase Domain of Wnk1
  104. 3fpm: Crystal Structure of a Squarate Inhibitor Bound to Mapkap Kinase-2
  105. 3fmd: Crystal Structure of Human Haspin with an Isoquinoline Ligand
  106. 3fl5: Protein Kinase Ck2 in Complex with The Inhibitor Quinalizarin
  107. 3fhr: High Resolution Crystal Structure of Mitogen-activated Protein Kinase-activated Protein Kinase 3 (mk3)-inhibitor Complex
  108. 3fe3: Crystal Structure of The Kinase Mark3/par-1: T211A-S215A Double Mutant
  109. 3fdn: Structure-based Drug Design of Novel Aurora Kinase a Inhibitors: Structure Basis for Potency and Specificity
  110. 3fbv: Crystal Structure of The Oligomer Formed by The Kinase- Ribonuclease Domain of Ire1
  111. 3f9n: Crystal Structure of Chk1 Kinase in Complex with Inhibitor 38
  112. 3f6q: Crystal Structure of Integrin-linked Kinase Ankyrin Repeat Domain in Complex with Pinch1 Lim1 Domain
  113. 3f69: Crystal Structure of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain in Complex with Kt5720
  114. 3f61: Crystal Structure of M. Tuberculosis Pknb LEU33ASP/VAL222ASP Double Mutant in Complex with Adp
  115. 3f5u: Crystal Structure of The Death Associated Protein Kinase in Complex with Amppnp and Mg2+
  116. 3f5g: Crystal Structure of Death Associated Protein Kinase in Complex with Adp and Mg2+
  117. 3f2n: Crystal Structure of Human Haspin with an Imidazo- Pyridazine Ligand
  118. 3f2a: Crystal Structure of Human Pim-1 in Complex with Dappa
  119. 3eha: Crystal Structure of Death Associated Protein Kinase Complexed with Amppnp
  120. 3eh9: Crystal Structure of Death Associated Protein Kinase Complexed with Adp
  121. 3efw: Structure of Auroraa with Pyridyl-pyrimidine Urea Inhibitor
  122. 3e8d: Crystal Structures of The Kinase Domain of Akt2 in Complex with Atp-competitive Inhibitors
  123. 3e88: Crystal Structures of The Kinase Domain of Akt2 in Complex with Atp-competitive Inhibitors
  124. 3e87: Crystal Structures of The Kinase Domain of Akt2 in Complex with Atp-competitive Inhibitors
  125. 3e7v: Crystal Structure of Human Haspin with a Pyrazolo- Pyrimidine Ligand
  126. 3e7e: Structure and Substrate Recruitment of The Human Spindle Checkpoint Kinase Bub
  127. 3e5a: Crystal Structure of Aurora a in Complex with Vx-680 and Tpx2
  128. 3e3b: Crystal Structure of Catalytic Subunit of Human Protein Kinase CK2ALPHA Prime with a Potent Indazole-derivative Inhibitor
  129. 3dvl: Crystal Structure of Full Length Circadian Clock Protein Kaic with Correct Geometry at Phosphorylation Sites
  130. 3dlz: Crystal Structure of Human Haspin in Complex with Amp
  131. 3dls: Crystal Structure of Human Pas Kinase Bound to Adp
  132. 3dj7: Crystal Structure of The Mouse Aurora-a Catalytic Domain (asn186->gly, Lys240->arg, Met302->leu) in Complex with Compound 130.
  133. 3dj6: Crystal Structure of The Mouse Aurora-a Catalytic Domain (asn186->gly, Lys240->arg, Met302->leu) in Complex with Compound 823.
  134. 3dj5: Crystal Structure of The Mouse Aurora-a Catalytic Domain (asn186->gly, Lys240->arg, Met302->leu) in Complex with Compound 290.
  135. 3dgk: Crystal Structure of a Glycine-rich Loop Mutant of The Death Associated Protein Kinase Catalytic Domain
  136. 3dfc: Crystal Structure of a Glycine-rich Loop Mutant of The Death Associated Protein Kinase Catalytic Domain with Amppnp
  137. 3dcv: Crystal Structure of Human Pim1 Kinase Complexed with 4-(4- Hydroxy-3-methyl-phenyl)-6-phenylpyrimidin-2(1h)-one
  138. 3dak: Crystal Structure of Domain-swapped Osr1 Kinase Domain
  139. 3dae: Crystal Structure of Phosphorylated Snf1 Kinase Domain
  140. 3d9v: Crystal Structure of Rock I Bound to H-1152p a Di- Methylated Variant of Fasudil
  141. 3d6t: Structure of The Roc Domain from The Parkinson's Disease- Associated Leucine-rich Repeat Kinase 2 Reveals a Dimeric Gtpase
  142. 3d4q: Pyrazole-based Inhibitors of B-raf Kinase
  143. 1ul7: Solution Structure of Kinase Associated Domain 1 of Mouse Map/microtubule Affinity-regulating Kinase 3
  144. 3d2k: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with [7-(2-{2-[3-(3-chloro- Phenyl)-ureido]-thiazol-5-yl}-ethylamino)-pyrazolo[4,3- D]pyrimidin-1-yl]-acetic Acid
  145. 3d2i: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with 1-{5-[2-(1-methyl-1h- Pyrazolo[4,3-d]pyrimidin-7-ylamino)-ethyl]-thiazol-2-yl}-3- (3-trifluoromethyl-phenyl)-urea
  146. 1unr: Crystal Structure of The Ph Domain of Pkb Alpha in Complex with a Sulfate Molecule
  147. 3d15: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with 1-(3-chloro-phenyl)-3- {5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)- Ethyl]-thiazol-2- Yl}-urea [sns-314]
  148. 3d14: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with 1-{5-[2-(thieno[3,2- D]pyrimidin-4-ylamino)-ethyl]- Thiazol-2-yl}-3-(3- Trifluoromethyl-phenyl)-urea
  149. 3d0e: Crystal Structure of Human Akt2 in Complex with Gsk690693
  150. 3cy3: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and The Jnk Inhibitor V
  151. 3cy2: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Beta Carboline Ligand II
  152. 3cxw: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Beta Carboline Ligand I
  153. 3cu8: Impaired Binding of 14-3-3 to Raf1 Is Linked to Noonan and Leopard Syndrome
  154. 3cqw: Crystal Structure of Akt-1 Complexed with Substrate Peptide and Inhibitor
  155. 3cqu: Crystal Structure of Akt-1 Complexed with Substrate Peptide and Inhibitor
  156. 3com: Crystal Structure of Mst1 Kinase
  157. 3coh: Crystal Structure of Aurora-a in Complex with a Pentacyclic Inhibitor
  158. 3ckx: Crystal Structure of Sterile 20-like Kinase 3 (mst3, Stk24) in Complex with Staurosporine
  159. 3ckw: Crystal Structure of Sterile 20-like Kinase 3 (mst3, Stk24)
  160. 3c4e: Pim-1 Kinase Domain in Complex with 3-aminophenyl-7- Azaindole
  161. 3c4d: B-raf Kinase V600E Oncogenic Mutant in Complex with Plx3203
  162. 3c4c: B-raf Kinase in Complex with Plx4720
  163. 3c13: Low Ph-value Crystal Structure of Emodin in Complex with The Catalytic Subunit of Protein Kinase Ck2
  164. 3c0i: Cask Cam-kinase Domain- 3'-amp Complex, P212121 Form
  165. 3c0h: Cask Cam-kinase Domain- Amppnp Complex, P1 Form
  166. 3c0g: Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
  167. 3bwf: Crystal Structure of The Human Pim1 in Complex with an Osmium Compound
  168. 3bqr: Crystal Structure of Human Death Associated Protein Kinase 3 (dapk3) in Complex with an Imidazo-pyridazine Ligand
  169. 3bqc: High Ph-value Crystal Structure of Emodin in Complex with The Catalytic Subunit of Protein Kinase Ck2
  170. 3bhy: Crystal Structure of Human Death Associated Protein Kinase 3 (dapk3) in Complex with a Beta-carboline Ligand
  171. 3bgz: Human Pim-1 Kinase in Complex with Diphenyl Indole Inhibitor Vx3
  172. 3bgq: Human Pim-1 Kinase in Complex with an Triazolo Pyridazine Inhibitor Vx2
  173. 3bgp: Human Pim-1 Complexed with a Benzoisoxazole Inhibitor Vx1
  174. 3beg: Crystal Structure of Sr Protein Kinase 1 Complexed to Its Substrate Asf/sf2
  175. 3be9: Structure-based Design and Synthesis of Novel Macrocyclic Pyrazolo[1,5-a] [1,3,5]triazine Compounds as Potent Inhibitors of Protein Kinase Ck2 and Their Anticancer Activities
  176. 1wak: X-ray Structure of Srpk1
  177. 3b43: I-band Fragment I65-i70 from Titin
  178. 3akl: Crystal Structure of a Helicobacter Pylori Proinflammatory Kinase Ctka
  179. 3akk: Crystal Structure of a Helicobacter Pylori Proinflammatory Kinase Ctka
  180. 3akj: Crystal Structure of a Helicobacter Pylori Proinflammatory Kinase Ctka
  181. 3aad: Structure of The Histone Chaperone Cia/asf1-double Bromodomain Complex Linking Histone Modifications and Site-specific Histone Eviction
  182. 3a99: Structure of Pim-1 Kinase Crystallized in The Presence of P27KIP1 Carboxy-terminal Peptide
  183. 3a62: Crystal Structure of Phosphorylated P70S6K1
  184. 3a61: Crystal Structure of Unphosphorylated P70S6K1 (form Ii)
  185. 3a60: Crystal Structure of Unphosphorylated P70S6K1 (form I)
  186. 3a2c: Crystal Structure of a Pyrazolopyrimidine Inhibitor Complex Bound to Mapkap Kinase-2 (mk2)
  187. 2zjw: Crystal Structure of Human Ck2 Alpha Complexed with Ellagic Acid
  188. 2zej: Structure of The Roc Domain from The Parkinson's Disease- Associated Leucine-rich Repeat Kinase 2 Reveals a Dimeric Gtpase
  189. 2z7s: Crystal Structure of The N-terminal Kinase Domain of Human Rsk1 Bound to Purvalnol a
  190. 2z7r: Crystal Structure of The N-terminal Kinase Domain of Human Rsk1 Bound to Staurosporine
  191. 2z7q: Crystal Structure of The N-terminal Kinase Domain of Human Rsk-1 Bound to Amp-pcp
  192. 2z6d: Crystal Structure of Lov1 Domain of Phototropin2 from Arabidopsis Thaliana
  193. 2z6c: Crystal Structure of Lov1 Domain of Phototropin1 from Arabidopsis Thaliana
  194. 2yza: Crystal Structure of Kinase Domain of Human 5'-amp- Activated Protein Kinase Alpha-2 Subunit Mutant (T172D)
  195. 2yz0: Solution Structure of Rwd/gi Domain of Saccharomyces Cerevisiae Gcn2
  196. 2ywp: Crystal Structure of Chk1 with a Urea Inhibitor
  197. 2yub: Solution Structure of The Pdz Domain from Mouse Lim Domain Kinase
  198. 2xru: Aurora-a T288E Complexed with Pha-828300
  199. 2xng: Structure of Aurora-a Bound to a Selective Imidazopyrazine Inhibitor
  200. 2xne: Structure of Aurora-a Bound to an Imidazopyrazine Inhibitor
  201. 2xkf: Structure of Nek2 Bound to Aminopyrazine Compound 2
  202. 2xke: Structure of Nek2 Bound to Aminipyrazine Compound 5
  203. 2xkd: Structure of Nek2 Bound to Aminopyrazine Compound 12
  204. 2xkc: Structure of Nek2 Bound to Aminopyrazine Compound 14
  205. 2xk8: Structure of Nek2 Bound to Aminopyrazine Compound 15
  206. 2xk7: Structure of Nek2 Bound to Aminopyrazine Compound 23
  207. 2xk6: Structure of Nek2 Bound to Aminopyrazine Compound 36
  208. 2xk4: Structure of Nek2 Bound to Aminopyrazine Compound 17
  209. 2xk3: Structure of Nek2 Bound to Aminopyrazine Compound 35
  210. 2xik: Structure of Human Ysk1 (yeast Sps1-ste20-related Kinase 1)
  211. 2xh5: Structure of 4-(4-tert-butylbenzyl)-1-(7h-pyrrolo(2,3-d) Pyrimidin-4-yl)piperidin-4-amine Bound to Pkb
  212. 2xf0: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  213. 2xez: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  214. 2xey: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  215. 2xck: Crystal Structure of Pdk1 in Complex with a Pyrazoloquinazoline Inhibitor
  216. 2xch: Crystal Structure of Pdk1 in Complex with a Pyrazoloquinazoline Inhibitor
  217. 2x8i: Discovery of a Novel Class of Triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration
  218. 2x8e: Discovery of a Novel Class of Triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration
  219. 2x8d: Discovery of a Novel Class of Triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration
  220. 2x81: Structure of Aurora a in Complex with Mln8054
  221. 2x7g: Structure of Human Serine-arginine-rich Protein-specific Kinase 2 (srpk2) Bound to Purvalanol B
  222. 2x7f: Crystal Structure of The Kinase Domain of Human Traf2- and Nck-interacting Kinase with WEE1CHK1 Inhibitor
  223. 2x6e: Aurora-a Bound to an Inhibitor
  224. 2x6d: Aurora-a Bound to an Inhibitor
  225. 2x4z: Crystal Structure of The Human P21-activated Kinase 4 in Complex with Pf-03758309
  226. 2x4f: The Crystal Structure of The Human Myosin Light Chain Kinase Loc340156.
  227. 2x39: Structure of 4-amino-n-(4-chlorobenzyl)-1-(7h-pyrrolo(2,3-d) Pyrimidin-4-yl)piperidine-4-carboxamide Bound to Pkb
  228. 2x18: The Crystal Structure of The Ph Domain of Human Akt3 Protein Kinase
  229. 2x0g: X-ray Structure of a Dap-kinase Calmodulin Complex
  230. 2wzj: Catalytic and Uba Domain of Kinase Mark2/(par-1) K82R, T208E Double Mutant
  231. 2wwm: Crystal Structure of The Titin M10-obscurin like 1 Ig Complex in Space Group P1
  232. 2wwk: Crystal Structure of The Titin M10-obscurin like 1 Ig F17R Mutant Complex
  233. 2wvi: Crystal Structure of The N-terminal Domain of Bubr1
  234. 2wtw: Aurora-a Inhibitor Structure (2nd Crystal Form)
  235. 2wtv: Aurora-a Inhibitor Structure
  236. 2wtk: Structure of The Heterotrimeric LKB1-STRADALPHA-MO25ALPHA Complex
  237. 2wtj: Crystal Structure of Chk2 in Complex with an Inhibitor
  238. 2wti: Crystal Structure of Chk2 in Complex with an Inhibitor
  239. 2wtd: Crystal Structure of Chk2 in Complex with an Inhibitor
  240. 2wtc: Crystal Structure of Chk2 in Complex with an Inhibitor
  241. 2wqo: Structure of Nek2 Bound to The Aminopyridine Cct241950
  242. 2wqn: Structure of Adp-bound Human Nek7
  243. 2wqm: Structure of Apo Human Nek7
  244. 2wqe: Structure of S155R Aurora-a Somatic Mutant
  245. 2wp3: Crystal Structure of The Titin M10-obscurin like 1 Ig Complex
  246. 2wnt: Crystal Structure of The Human Ribosomal Protein S6 Kinase
  247. 2wmx: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  248. 2wmw: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  249. 2wmv: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  250. 2wmu: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  251. 2wmt: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  252. 2wms: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  253. 2wmr: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  254. 2wmq: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  255. 2wiu: Mercury-modified Bacterial Persistence Regulator Hipba
  256. 2wb8: Crystal Structure of Haspin Kinase
  257. 2w7x: Cellular Inhibition of Checkpoint Kinase 2 and Potentiation of Cytotoxic Drugs by Novel Chk2 Inhibitor Pv1019
  258. 2w7r: Structure of The Pdz Domain of Human Microtubule Associated Serine-threonine Kinase 4
  259. 2w5h: Human Nek2 Kinase Apo
  260. 2w5b: Human Nek2 Kinase Atpgammas-bound
  261. 2w5a: Human Nek2 Kinase Adp-bound
  262. 2w4k: X-ray Structure of a Dap-kinase 2-302
  263. 2w4j: X-ray Structure of a Dap-kinase 2-277
  264. 2w1g: Structure Determination of Aurora Kinase in Complex with Inhibitor
  265. 2w1f: Structure Determination of Aurora Kinase in Complex with Inhibitor
  266. 2w1e: Structure Determination of Aurora Kinase in Complex with Inhibitor
  267. 2w1d: Structure Determination of Aurora Kinase in Complex with Inhibitor
  268. 2w1c: Structure Determination of Aurora Kinase in Complex with Inhibitor
  269. 2w0j: Crystal Structure of Chk2 in Complex with Nsc 109555, a Specific Inhibitor
  270. 2vwi: Structure of The Osr1 Kinase, a Hypertension Drug Target
  271. 2vuw: Structure of Human Haspin Kinase Domain
  272. 2vu3: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  273. 2vtt: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  274. 2vts: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  275. 2vtr: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  276. 2vtq: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  277. 2vtp: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  278. 2vto: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  279. 2vtn: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  280. 2vtm: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  281. 2vtl: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  282. 2vtj: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  283. 2vti: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  284. 2vth: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
  285. 2vrx: Structure of Aurora B Kinase in Complex with Zm447439
  286. 2vki: Structure of The Pdk1 Ph Domain K465E Mutant
  287. 2a38: Crystal Structure of The N-terminus of Titin
  288. 2vgp: Crystal Structure of Aurora B Kinase in Complex with a Aminothiazole Inhibitor
  289. 2vgo: Crystal Structure of Aurora B Kinase in Complex with Reversine Inhibitor
  290. 2vd5: Structure of Human Myotonic Dystrophy Protein Kinase in Complex with The Bisindoylmaleide Inhibitor Bim VIII
  291. 2v9j: Crystal Structure of The Regulatory Fragment of Mammalian Ampk in Complexes with Mg.atp-amp
  292. 2v92: Crystal Structure of The Regulatory Fragment of Mammalian Ampk in Complexes with Atp-amp
  293. 2v8q: Crystal Structure of The Regulatory Fragment of Mammalian Ampk in Complexes with Amp
  294. 2v62: Structure of Vaccinia-related Kinase 2
  295. 2v55: Mechanism of Multi-site Phosphorylation from a Rock-i:rhoe Complex Structure
  296. 2v3s: Structural Insights into The Recognition of Substrates and Activators by The Osr1 Kinase
  297. 2uzs: A Transforming Mutation in The Pleckstrin Homology Domain of Akt1 in Cancer (AKT1-PH_E17K)
  298. 2uzr: A Transforming Mutation in The Pleckstrin Homology Domain of Akt1 in Cancer (AKT1-PH_E17K)
  299. 2uw9: Structure of Pkb-beta (akt2) Complexed with 4-(4-chloro- Phenyl)-4-(4-(1h-pyrazol-4-yl)-phenyl)-piperidine
  300. 2uvm: Structure of Pkbalpha Ph Domain in Complex with a Novel Inositol Headgroup Surrogate, Benzene 1,2,3,4- Tetrakisphosphate
  301. 2uv2: Crystal Structure of Human Ste20-like Kinase Bound to 4-(4-( 5-cyclopropyl-1h-pyrazol-3-ylamino)-quinazolin-2-ylamino)- Phenyl)-acetonitrile
  302. 2uue: Replace: a Strategy for Iterative Design of Cyclin Binding Groove Inhibitors
  303. 2rq8: Solution Nmr Structure of Titin I27 Domain Mutant
  304. 2row: The C1 Domain of Rock II
  305. 2rov: The Split Ph Domain of Rock II
  306. 2rjm: 3ig Structure of Titin Domains I67-i69 E-to-a Mutated Variant
  307. 2rio: Structure of The Dual Enzyme Ire1 Reveals The Basis for Catalysis and Regulation of Non-conventional Splicing
  308. 2rik: I-band Fragment I67-i69 from Titin
  309. 2r7i: Crystal Structure of Catalytic Subunit of Protein Kinase Ck2
  310. 2r7b: Crystal Structure of The Phosphoinositide-dependent Kinase- 1 (pdk-1)catalytic Domain Bound to a Dibenzonaphthyridine Inhibitor
  311. 2r5t: Crystal Structure of Inactive Serum and Glucocorticoid- Regulated Kinase 1 in Complex with Amp-pnp
  312. 2r0u: Crystal Structure of Chek1 in Complex with Inhibitor 54
  313. 2r0i: Crystal Structure of a Kinase Mark2/par-1 Mutant
  314. 2qre: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with 5-aminoimidazole- 4-carboxamide 1-beta-d-ribofuranotide (zmp)
  315. 2qrd: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with Adp and Atp
  316. 2qrc: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with Adp and Amp
  317. 2qr8: 2.0a X-ray Structure of C-terminal Kinase Domain of P90 Ribosomal S6 Kinase 2 (rsk2)
  318. 2qr7: 2.0a X-ray Structure of C-terminal Kinase Domain of P90 Ribosomal S6 Kinase 2: Se-met Derivative
  319. 2qr1: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with Adp
  320. 2qnj: Kinase and Ubiquitin-associated Domains of Mark3/par-1
  321. 2qme: Crystal Structure of Human Rac3 in Complex with Crib Domain of Human P21-activated Kinase 1 (pak1)
  322. 2qlv: Crystal Structure of The Heterotrimer Core of The S. Cerevisiae Ampk Homolog Snf1
  323. 2qkw: Structural Basis for Activation of Plant Immunity by Bacterial Effector Protein Avrpto
  324. 2qhn: Crystal Structure of Chek1 in Complex with Inhibitor 1a
  325. 2qhm: Crystal Structure of Chek1 in Complex with Inhibitor 2a
  326. 2cke: Human Death-associated Drp-1 Kinase in Complex with Inhibitor
  327. 2qc6: Protein Kinase Ck2 in Complex with Dbc
  328. 2cmw: Structure of Human Casein Kinase 1 Gamma-1 in Complex with 2-(2-hydroxyethylamino)-6-(3-chloroanilino)-9- Isopropylpurine (casp Target)
  329. 2cn5: Crystal Structure of Human Chk2 in Complex with Adp
  330. 2cn8: Crystal Structure of Human Chk2 in Complex with Debromohymenialdisine
  331. 2q0n: Structure of Human P21 Activating Kinase 4 (pak4) in Complex with a Consensus Peptide
  332. 2pzy: Structure of Mk2 Complexed with Compound 76
  333. 2pzi: Crystal Structure of Protein Kinase Pkng from Mycobacterium Tuberculosis in Complex with Tetrahydrobenzothiophene Ax20017
  334. 2pvr: Crystal Structure of The Catalytic Subunit of Protein Kinase Ck2 (c-terminal Deletion Mutant 1-335) in Complex with Two Sulfate Ions
  335. 2pvn: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  336. 2pvm: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  337. 2pvl: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  338. 2pvk: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  339. 2pvj: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  340. 2pvh: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  341. 2pe2: Crystal Structure of Human Phosphoinositide-dependent Protein Kinase 1 (pdk1) 3-{5-[2-oxo-5-ureido-1,2-dihydro- Indol-(3z)-ylidenemethyl]-1h-pyrrol-3-yl}-n-(2-piperidin-1- Yl-ethyl)-benzamide Complex
  342. 2pe1: Crystal Structure of Human Phosphoinositide-dependent Protein Kinase 1 (pdk1) {2-oxo-3-[1-(1h-pyrrol-2-yl)-eth- (z)-ylidene]-2,3-dihydro-1h-indol-5-yl}-urea {bx-517} Complex
  343. 2pe0: Crystal Structure of Human Phosphoinositide-dependent Protein Kinase 1 (pdk1) 5-hydroxy-3-[1-(1h-pyrrol-2-yl)- Eth-(z)-ylidene]-1,3-dihydro-indol-2-one Complex
  344. 2p3g: Crystal Structure of a Pyrrolopyridine Inhibitor Bound to Mapkap Kinase-2
  345. 2oza: Structure of P38ALPHA Complex
  346. 2oxy: Protein Kinase Ck2 in Complex with Tetrabromobenzoimidazole Derivatives K17, K22 and K32
  347. 2oxx: Protein Kinase Ck2 in Complex with Tetrabromobenzoimidazole Derivatives K17, K22 and K32
  348. 2oxd: Protein Kinase Ck2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors
  349. 2ov2: The Crystal Structure of The Human Rac3 in Complex with The Crib Domain of Human P21-activated Kinase 4 (pak4)
  350. 2ooy: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase Complexed with Atp
  351. 2oox: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase Complexed with Amp
  352. 2onl: Crystal Structure of The P38A-MAPKAP Kinase 2 Heterodimer
  353. 2okr: Crystal Structure of The P38A-MAPKAP Kinase 2 Heterodimer
  354. 2oid: Crystal Structure of Irak4 Kinase Domain Complexed with Amppnp
  355. 2oic: Crystal Structure of Irak4 Kinase Domain Complexed with Staurosporine
  356. 2oib: Crystal Structure of Irak4 Kinase Domain Apo Form
  357. 2oi4: Crystal Structure of Human Pim1 in Complex with Fluorinated Ruthenium Pyridocarbazole
  358. 2obj: Crystal Structure of Human Pim-1 Kinase in Complex with Inhibitor
  359. 2o8y: Apo Irak4 Kinase Domain
  360. 2dwb: Aurora-a Kinase Complexed with Amppnp
  361. 2o65: Crystal Structure of Pim1 with Pentahydroxyflavone
  362. 2o64: Crystal Structure of Pim1 with Quercetagetin
  363. 2o63: Crystal Structure of Pim1 with Myricetin
  364. 2o3p: Crystal Structure of Pim1 with Quercetin
  365. 2nzi: Crystal Structure of Domains A168-a170 from Titin
  366. 2nry: Crystal Structure of Irak-4
  367. 2nru: Crystal Structure of Irak-4
  368. 2e9n: Structure of H-chk1 Complexed with A767085
  369. 2e9o: Structure of H-chk1 Complexed with Aa582939
  370. 2e9p: Structure of H-chk1 Complexed with A771129
  371. 2e9u: Structure of H-chk1 Complexed with A780125
  372. 2e9v: Structure of H-chk1 Complexed with A859017
  373. 2np8: Structural Basis for The Inhibition of Aurora a Kinase by a Novel Class of High Affinity Disubstituted Pyrimidine Inhibitors
  374. 2ehb: The Structure of The C-terminal Domain of The Protein Kinase Atsos2 Bound to The Calcium Sensor Atsos3
  375. 2l05: Solution Nmr Structure of The Ras-binding Domain of Serine/threonine- Protein Kinase B-raf from Homo Sapiens, Northeast Structural Genomics Consortium Target HR4694F
  376. 2kui: Nmr Structure of The Pasta Domain of Mycobacterium Tuberculosis of Pknb
  377. 2kuf: Nmr Structure of The Pasta Domain 3 and 4 of Mycobacterium Tuberculosis of Pknb
  378. 2kue: Nmr Structure of The Pasta Domain 2 and 3 of Mycobacterium Tuberculosis of Pknb
  379. 2kud: Nmr Structure of The Pasta Domain 1 and 2 of Mycobacterium Tuberculosis of Pknb
  380. 2h34: Apoenzyme Crystal Structure of The Tuberculosis Serine/threonine Kinase, Pkne
  381. 2h6d: Protein Kinase Domain of The Human 5'-amp-activated Protein Kinase Catalytic Subunit Alpha-2 (ampk Alpha-2 Chain)
  382. 2h9v: Structural Basis for Induced-fit Binding of Rho-kinase to The Inhibitor Y27632
  383. 2hak: Catalytic and Ubiqutin-associated Domains of Mark1/par-1
  384. 2hog: Crystal Structure of Chek1 in Complex with Inhibitor 20
  385. 2hw6: Crystal Structure of Mnk1 Catalytic Domain
  386. 2hw7: Crystal Structure of MNK2-D228G in Complex with Staurosporine
  387. 2hxl: Crystal Structure of Chek1 in Complex with Inhibitor 1
  388. 2hxq: Crystal Structure of Chek1 in Complex with Inhibitor 2
  389. 2hy0: Crystal Structure of Chek1 in Complex with Inhibitor 22
  390. 2hy8: Pak1 Complex with St2001
  391. 2i3s: Bub3 Complex with Bub1 Glebs Motif
  392. 2ill: Anomalous Substructure of Titin-a168169
  393. 2iwi: Crystal Structure of The Human Pim2 in Complex with a Ruthenium Organometallic Ligand Ru1
  394. 2izr: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
  395. 2izs: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
  396. 2izt: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
  397. 2izu: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
  398. 2j0i: Crystal Structure of The Human P21-activated Kinase 4
  399. 2j2i: Crystal Structure of The Humab Pim1 in Complex with Ly333531
  400. 2j4z: Structure of Aurora-2 in Complex with Pha-680626
  401. 2j50: Structure of Aurora-2 in Complex with Pha-739358
  402. 2j51: Crystal Structure of Human Ste20-like Kinase Bound to 5- Amino-3-((4-(aminosulfonyl)phenyl)amino)-n-(2,6- Difluorophenyl)-1h-1,2,4-triazole-1-carbothioamide
  403. 2j7t: Crystal Structure of Human Serine Threonine Kinase-10 Bound to Su11274
  404. 2j8h: Structure of The Immunoglobulin Tandem Repeat A168-a169 of Titin
  405. 2j8o: Structure of The Immunoglobulin Tandem Repeat of Titin A168- A169
  406. 2j90: Crystal Structure of Human Zip Kinase in Complex with a Tetracyclic Pyridone Inhibitor (pyridone 6)
  407. 2jbo: Protein Kinase Mk2 in Complex with an Inhibitor (crystal Form-1, Soaking)
  408. 2jbp: Protein Kinase Mk2 in Complex with an Inhibitor (crystal Form-2, Co-crystallization)
  409. 2jd5: SKY1P Bound to NPL3P-DERIVED Substrate Peptide
  410. 2jdo: Structure of Pkb-beta (akt2) Complexed with Isoquinoline-5- Sulfonic Acid (2-(2-(4-chlorobenzyloxy) Ethylamino)ethyl) Amide
  411. 2jdr: Structure of Pkb-beta (akt2) Complexed with The Inhibitor A- 443654
  412. 2jfl: Crystal Structure of Human Ste20-like Kinase ( Diphosphorylated Form) Bound to 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-n-(2,6- Difluorophenyl)-1h-1,2, 4-triazole-1-carbothioamide
  413. 2jfm: Crystal Structure of Human Ste20-like Kinase (unliganded Form)
  414. 2jii: Structure of Vaccinia Related Kinase 3
  415. 2jo8: Solution Structure of C-terminal Domain of Human Mammalian Sterile 20-like Kinase 1 (mst1)
  416. 2jqi: Nmr Structure of The Rad53 Fha1 Domain in Complex with a Phosphothreonien Peptide Derived from Rad53 Scd1
  417. 2jqj: Nmr Structure of Yeast Dun1 Fha Domain
  418. 2jql: Nmr Structure of The Yeast Dun1 Fha Domain in Complex with a Doubly Phosphorylated (pt) Peptide Derived from Rad53 Scd1
  419. 2kbx: Solution Structure of Ilk-pinch Complex
  420. 2kio: Nmr Structure of The Oxidized Yeast Tor1 Fatc Domain Bound to Dpc Micelles at 318k
  421. 2kit: The Solution Struture of The Reduced Yeast Tor1 Fatc Domain Bound to Dpc Micelles at 298k
  422. 3ncz: X-ray Co-structure of Rho-associated Protein Kinase (rock1) with a Potent 2h-isoquinolin-1-one Inhibitor
  423. 3pa3: X-ray Crystal Structure of Compound 70 Bound to Human Chk1 Kinase Domain
  424. 3pa4: X-ray Crystal Structure of Compound 2a Bound to Human Chk1 Kinase Domain
  425. 3pa5: X-ray Crystal Structure of Compound 1 Bound to Human Chk1 Kinase Domain
  426. 3pm8: Cad Domain of PFF0520W, Calcium Dependent Protein Kinase
  427. 2kr9: Kalirin Dh1 Nmr Structure
  428. 2kty: Solution Structure of Human Vaccinia Related Kinase-1
  429. 2kul: Solution Structure of Human Vaccinia Related Kinase 1(vrk1)
  430. 2xbj: Crystal Structure of Chk2 in Complex with an Inhibitor
  431. 2xix: Protein Kinase Pim-1 in Complex with Fragment-1 from Crystallographic Fragment Screen
  432. 2xiy: Protein Kinase Pim-1 in Complex with Fragment-2 from Crystallographic Fragment Screen
  433. 2xiz: Protein Kinase Pim-1 in Complex with Fragment-3 from Crystallographic Fragment Screen
  434. 2xj0: Protein Kinase Pim-1 in Complex with Fragment-4 from Crystallographic Fragment Screen
  435. 2xj1: Protein Kinase Pim-1 in Complex with Small Molecule Inibitor
  436. 2xj2: Protein Kinase Pim-1 in Complex with Small Molecule Inhibitor
  437. 2xm8: Co-crystal Structure of a Small Molecule Inhibitor Bound to The Kinase Domain of Chk2
  438. 2xm9: Structure of a Small Molecule Inhibitor with The Kinase Domain of Chk2
  439. 2y9r: Crystal Structure of The M10 Domain of Titin
  440. 3nga: Human Ck2 Catalytic Domain in Complex with Cx-4945
  441. 3nsz: Human Ck2 Catalytic Domain in Complex with Amppn
  442. 3ofm: Structure of a Human CK2ALPHA Prime, The Paralog Isoform of The Catalytic Subunit of Protein Kinase Ck2 from Homo Sapiens
  443. 3ose: Structure of The Kinase Associated Domain 1 (ka1) from Mark1 Kinase
  444. 3osm: Structure of The Kinase Associated Domain-1 (ka1) from KCC4P
  445. 3ost: Structure of The Kinase Associated-1 (ka1) from KCC4P
  446. 3p23: Crystal Structure of The Human Kinase and Rnase Domains in Complex with Adp
  447. 3pcs: Structure of Espg-pak2 Autoinhibitory Ialpha3 Helix Complex
  448. 3ppj: Human B-raf Kinase in Complex with a Furopyridine Inhibitor
  449. 3ppk: Human B-raf Kinase in Complex with a Non-oxime Furopyridine Inhibitor
  450. 3prf: Crystal Structure of Human B-raf Kinase Domain in Complex with a Non- Oxime Furopyridine Inhibitor
  451. 3pri: Crystal Structure of Human B-raf Kinase in Complex with a Non-oxime Furopyridine Inhibitor
  452. 3ps4: Pdz Domain from Human Microtubule-associated Serine/threonine-protein Kinase 1
  453. 3psb: Furo[2,3-c]pyridine-based Indanone Oximes as Potent and Selective B- Raf Inhibitors
  454. 3pvg: Crystal Structure of Z. Mays Ck2 Alpha Subunit in Complex with The Inhibitor 4,5,6,7-tetrabromo-1-carboxymethylbenzimidazole (k68)
  455. 3q4c: Crystal Structure of Wild Type Braf Kinase Domain in Complex with Organometallic Inhibitor Cns292
  456. 3q5z: Crystal Structure of Virulent Allele ROP5B Pseudokinase Domain
  457. 3q60: Crystal Structure of Virulent Allele ROP5B Pseudokinase Domain Bound to Atp
  458. 3qf9: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Furan- Thiazolidinedione Ligand
  459. 2xnm: Structure of Nek2 Bound to Cct
  460. 2xnn: Structure of Nek2 Bound to Cct242430
  461. 2xno: Structure of Nek2 Bound to Cct243779
  462. 2xnp: Structure of Nek2 Bound to Cct244858
  463. 2y8l: Structure of The Regulatory Fragment of Mammalian Ampk in Complex with Two Adp
  464. 2y8q: Structure of The Regulatory Fragment of Mammalian Ampk in Complex with One Adp
  465. 2y94: Structure of an Active Form of Mammalian Ampk
  466. 2ya3: Structure of The Regulatory Fragment of Mammalian Ampk in Complex with Coumarin Adp
  467. 2ya9: Crystal Structure of The Autoinhibited Form of Mouse Dapk2
  468. 2yaa: Crystal Structure of The Autoinhibited Form of Mouse Dapk2 in Complex with Atp
  469. 2yab: Crystal Structure of The Autoinhibited Form of Mouse Dapk2 in Complex with Amp
  470. 2yak: Structure of Death-associated Protein Kinase 1 (dapk1) in Complex with a Ruthenium Octasporine Ligand (osv)
  471. 3aqv: Human Amp-activated Protein Kinase Alpha 2 Subunit Kinase Domain (T172D) Complexed with Compound C
  472. 3m11: Crystal Structure of Aurora a Kinase Complexed with Inhibitor
  473. 3m42: Crystal Structure of Mapkap Kinase 2 (mk2) Complexed with a Tetracyclic Atp Site Inhibitor
  474. 3o0z: Crystal Structure of a Coiled-coil Domain from Human Rock I
  475. 3orx: Pdk1 Mutant Bound to Allosteric Disulfide Fragment Inhibitor 1f8
  476. 3orz: Pdk1 Mutant Bound to Allosteric Disulfide Fragment Activator 2a2
  477. 3otu: Pdk1 Mutant Bound to Allosteric Disulfide Fragment Activator Js30
  478. 3p9j: Aurora a Kinase Domain with Phthalazinone Pyrazole Inhibitor
  479. 3pwy: Crystal Structure of an Extender (spd28345)-modified Human Pdk1 Complex 2
  480. 3q96: B-raf Kinase Domain in Complex with a Tetrahydronaphthalene Inhibitor
  481. 3qc4: Pdk1 in Complex with Dfg-out Inhibitor XXX
  482. 3qcq: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 6-(3- Amino-1h-indazol-6-yl)-n4-ethyl-2,4-pyrimidinediamine
  483. 3qcs: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 6-[2- Amino-6-(4-morpholinyl)-4-pyrimidinyl]-1h-indazol-3-amine
  484. 3qcx: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 6-{2- Amino-6-[(3r)-3-methyl-4-morpholinyl]-4-pyrimidinyl}-1h-indazol-3- Amine
  485. 3qcy: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 4-[2- Amino-6-(3-amino-1h-indazol-6-yl)-4-pyrimidinyl]-n-phenyl-2- Morpholinecarboxamide
  486. 3qd0: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with (2r,5s)- 1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4-pyrimidinyl]-6-methyl-n- Phenyl-3-piperidinecarboxamide
  487. 3qd2: Crsytal Structure of Mouse Perk Kinase Domain
  488. 3qd3: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 1,1- Dimethylethyl {(3r,6s)-1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4- Pyrimidinyl]-6-methyl-3-piperidinyl}carbamate
  489. 3qd4: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 1,1- Dimethylethyl{(3r,5r)-1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4- Pyrimidinyl]-5-methyl-3-piperidinyl}carbamate
  490. 3qkk: Spirochromane Akt Inhibitors
  491. 3qkl: Spirochromane Akt Inhibitors
  492. 3qkm: Spirocyclic Sulfonamides as Akt Inhibitors
  493. 2lav: Nmr Solution Structure of Human Vaccinia-related Kinase 1
  494. 2lah: Solution Nmr Structure of Mitotic Checkpoint Serine/threonine-protein Kinase Bub1 N-terminal Domain from Homo Sapiens, Northeast Structural Genomics Consortium Target HR5460A (methods Development)
  495. 3r00: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
  496. 3r01: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
  497. 3r02: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
  498. 3r04: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
  499. 3lcy: Titin Ig Tandem Domains A164-a165
  500. 3nlb: Novel Kinase Profile Highlights The Temporal Basis of Context Dependent Checkpoint Pathways to Cell Death
  501. 3psd: Non-oxime Pyrazole Based Inhibitors of B-raf Kinase
  502. 3r1n: Mk3 Kinase Bound to Compound 5b
  503. 3r2b: Mk2 Kinase Bound to Compound 5b
  504. 3r2y: Mk2 Kinase Bound to Compound 1
  505. 3r30: Mk2 Kinase Bound to Compound 2
  506. 2kyl: Solution Structure of Mast2-pdz Complexed with The C-terminus of Pten
  507. 3rcj: Rapid Preparation of Triazolyl Substituted Nh-heterocyclic Kinase Inhibitors via One-pot Sonogashira Coupling Tms-deprotection Cuaac Sequence
  508. 3rgx: Structural Insight into Brassinosteroid Perception by Bri1
  509. 3rgz: Structural Insight into Brassinosteroid Perception by Bri1
  510. 3riz: Crystal Structure of The Plant Steroid Receptor Bri1 Ectodomain
  511. 3rj0: Plant Steroid Receptor Bri1 Ectodomain in Complex with Brassinolide
  512. 3rp0: Structure of Human CK2ALPHA in Complex with a Non-hydrolysable Atp- Analogue and Magnesium Ions
  513. 3rps: Structure of Human CK2ALPHA in Complex with The Atp-competitive Inhibitor 3-(4,5,6,7-tetrabromo-1h-benzotriazol-1-yl)propan-1-ol
  514. 3s95: Crystal Structure of The Human Limk1 Kinase Domain in Complex with Staurosporine
  515. 3sdj: Structure of Rnase-inactive Point Mutant of Oligomeric Kinase/rnase Ire1
  516. 3sdm: Structure of Oligomeric Kinase/rnase Ire1 in Complex with an Oligonucleotide
  517. 3r21: Design, Synthesis, and Biological Evaluation of Pyrazolopyridine- Sulfonamides as Potent Multiple-mitotic Kinase (mmk) Inhibitors (part I)
  518. 3r22: Design, Synthesis, and Biological Evaluation of Pyrazolopyridine- Sulfonamides as Potent Multiple-mitotic Kinase (mmk) Inhibitors (part I)
  519. 3skc: Human B-raf Kinase in Complex with an Amide Linked Pyrazolopyridine Inhibitor
  520. 2yiq: Structural Analysis of Checkpoint Kinase 2 in Complex with Inhibitor Pv1322
  521. 2yir: Structural Analysis of Checkpoint Kinase 2 in Complex with Inhibitor Pv1352
  522. 2yit: Structural Analysis of Checkpoint Kinase 2 in Complex with Pv1162, a Novel Inhibitor
  523. 3pe1: Crystal Structure of Human Protein Kinase Ck2 Alpha Subunit in Complex with The Inhibitor Cx-4945
  524. 3pe2: Crystal Structure of Human Protein Kinase Ck2 in Complex with The Inhibitor Cx-5011
  525. 3s1a: Crystal Structure of The Phosphorylation-site Double Mutant S431E/T432E of The Kaic Circadian Clock Protein
  526. 3amy: Crystal Structure of Human Ck2 Alpha Complexed with Apigenin
  527. 3t9i: Pim1 Complexed with a Novel 3,6-disubstituted Indole at 2.6 Ang Resolution
  528. 3tac: Crystal Structure of The Liprin-alpha/cask Complex
  529. 3tku: Mrck Beta in Complex with Fasudil
  530. 3tv4: Human B-raf Kinase Domain in Complex with an Bromopyridine Benzamide Inhibitor
  531. 3tv6: Human B-raf Kinase Domain in Complex with a Methoxypyrazolopyridinyl Benzamide Inhibitor
  532. 3zut: The Structure of Ost1 (D160A) Kinase
  533. 3zuu: The Structure of Ost1 (D160A, S175D) Kinase in Complex with Gold
  534. 3p86: Crystal Structure of Ctr1 Kinase Domain Mutant D676N in Complex with Staurosporine
  535. 3sc1: Novel Isoquinolone Pdk1 Inhibitors Discovered through Fragment-based Lead Discovery
  536. 3si5: Kinetochore-bubr1 Kinase Complex
  537. 2xuu: Crystal Structure of a Dap-kinase 1 Mutant
  538. 3at2: Crystal Structure of CK2ALPHA
  539. 3at3: Crystal Structure of CK2ALPHA with Pyradine Derivative
  540. 3at4: Crystal Structure of CK2ALPHA with Pyradine Derivertive
  541. 3pwd: Crystal Structure of Maize Ck2 in Complex with Nbc (z1)
  542. 3t4n: Structure of The Regulatory Fragment of Saccharomyces Cerevisiae Ampk in Complex with Adp
  543. 3tdh: Structure of The Regulatory Fragment of Sccharomyces Cerevisiae Ampk in Complex with Amp
  544. 3te5: Structure of The Regulatory Fragment of Sacchromyces Cerevisiae Ampk in Complex with Nadh
  545. 3zz2: Crystal Structure of Human Serine Threonine Kinase-10 Bound to Bosutinib
  546. 2ycf: Crystal Structure of Checkpoint Kinase 2 in Complex with Inhibitor Pv1531
  547. 2ycq: Crystal Structure of Checkpoint Kinase 2 in Complex with Inhibitor Pv1115
  548. 2ycr: Crystal Structure of Checkpoint Kinase 2 in Complex with Inhibitor Pv976
  549. 2ycs: Crystal Structure of Checkpoint Kinase 2 in Complex with Pv788
  550. 3rwp: Discovery of a Novel, Potent and Selective Inhibitor of 3- Phosphoinositide Dependent Kinase (pdk1)
  551. 3rwq: Discovery of a Novel, Potent and Selective Inhibitor of 3- Phosphoinositide Dependent Kinase (pdk1)
  552. 3tax: A Neutral Diphosphate Mimic Crosslinks The Active Site of Human O- Glcnac Transferase
  553. 3udb: Crystal Structure of Snrk2.6
  554. 2xzs: Death Associated Protein Kinase 1 Residues 1-312
  555. 2y0a: Structure of Dapk1 Construct Residues 1-304
  556. 3ppz: Crystal Structure of Ctr1 Kinase Domain in Complex with Staurosporine
  557. 3puc: Atomic Resolution Structure of Titin Domain M7
  558. 3pzh: Crystal Structure of Maize Ck2 Alpha in Complex with Emodin at 1.92 a Resolution
  559. 3q04: Crystal Structure of The Apo-form of Human Ck2 Alpha at Ph 8.5
  560. 3q4z: Structure of Unphosphorylated Pak1 Kinase Domain
  561. 3q52: Structure of Phosphorylated Pak1 Kinase Domain
  562. 3q53: Structure of Phosphorylated Pak1 Kinase Domain in Complex with Atp
  563. 3r0t: Crystal Structure of Human Protein Kinase Ck2 Alpha Subunit in Complex with The Inhibitor Cx-5279
  564. 3she: Novel Atp-competitive Mk2 Inhibitors with Potent Biochemical and Cell- Based Activity throughout The Series
  565. 3uc3: The Crystal Structure of Snf1-related Kinase 2.3
  566. 3uc4: The Crystal Structure of Snf1-related Kinase 2.6
  567. 4a06: Human Pdk1 Kinase Domain in Complex with Allosteric Activator Ps114 Bound to The Pif-pocket
  568. 4a07: Human Pdk1 Kinase Domain in Complex with Allosteric Activator Ps171 Bound to The Pif-pocket
  569. 2y4v: Crystal Structure of Human Calmodulin in Complex with a Dap Kinase-1 Mutant (W305Y) Peptide
  570. 4a55: Crystal Structure of P110ALPHA in Complex with Ish2 of P85ALPHA and The Inhibitor Pik-108
  571. 2ym3: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  572. 2ym4: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  573. 2ym5: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  574. 2ym6: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  575. 2ym7: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  576. 2ym8: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  577. 3q9w: Crystal Structure of Human Ck2 Alpha in Complex with Emodin at Ph 8.5
  578. 3q9x: Crystal Structure of Human Ck2 Alpha in Complex with Emodin at Ph 6.5
  579. 3q9y: Crystal Structure of Human Ck2 Alpha in Complex with Quinalizarin at Ph 8.5
  580. 3q9z: Crystal Structure of Human Ck2 Alpha in Complex with Quinalizarin at Ph 6.5
  581. 3qa0: Crystal Structure of The Apo-form of Human Ck2 Alpha at Ph 6.5
  582. 3tl8: The Avrptob-bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains in a Single Type III Effector
  583. 3uys: Crystal Structure of Apo Human CK1D
  584. 3uyt: Crystal Structure of CK1D with Pf670462 from P1 Crystal Form
  585. 3uzp: Crystal Structure of CK1D with Pf670462 from P21 Crystal Form
  586. 2y4p: Dimeric Structure of Dapk-1 Catalytic Domain
  587. 3qbn: Structure of Human Aurora a in Complex with a Diaminopyrimidine
  588. 3uv5: Crystal Structure of The Tandem Bromodomains of Human Transcription Initiation Factor Tfiid Subunit 1 (taf1)
  589. 2ydj: Discovery of Checkpoint Kinase Inhibitor Azd7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas
  590. 3u9n: X-ray Crystal Structure of Compound 1 Bound to Human Chk1 Kinase Domain
  591. 3unz: Aurora a in Complex with Rpm1679
  592. 3uo4: Aurora a in Complex with Rpm1680
  593. 3uo5: Aurora a in Complex with Yl1-038-31
  594. 3uo6: Aurora a in Complex with Yl5-083
  595. 3uod: Aurora a in Complex with Rpm1693
  596. 3uoh: Aurora a in Complex with Rpm1722
  597. 3uoj: Aurora a in Complex with Rpm1715
  598. 3uok: Aurora a in Complex with Yl5-81-1
  599. 3uol: Aurora a in Complex with So2-162
  600. 3up2: Aurora a in Complex with Rpm1686
  601. 3up7: Aurora a in Complex with Yl1-038-09
  602. 2lcs: Yeast NBP2P Sh3 Domain in Complex with a Peptide from STE20P
  603. 3q5o: Crystal Structure of Human Titin Domain M10
  604. 3ztx: Aurora Kinase Selective Inhibitors Identified Using a Taxol- Induced Checkpoint Sensitivity Screen.
  605. 3v8s: Human Rho-associated Protein Kinase 1 (rock 1) in Complex with Indazole Derivative (compound 18)
  606. 2ygv: Conserved N-terminal Domain of The Yeast Histone Chaperone Asf1 in Complex with The C-terminal Fragment of Rad53
  607. 3qp3: Crystal Structure of Titin Domain M4, Tetragonal Form
  608. 3tv7: Human Rho-associated Protein Kinase 1 (rock 1) in Complex with Rki1342
  609. 3ujg: Crystal Structure of Snrk2.6 in Complex with Hab1
  610. 4a7c: Crystal Structure of Pim1 Kinase with Etp46546
  611. 4dit: Crystal Structure of GSK3BETA in Complex with a Imidazolopyridine Inhibitor
  612. 3ua2: Crystal Structure of Circadian Clock Protein Kaic E318A Mutant
  613. 2y9q: Crystal Structure of Human Erk2 Complexed with a Mapk Docking Peptide
  614. 4a1g: The Crystal Structure of The Human Bub1 Tpr Domain in Complex with The Ki Motif of Knl1
  615. 4afj: 5-aryl-4-carboxamide-1,3-oxazoles: Potent and Selective Gsk-3 Inhibitors
  616. 2yer: Synthesis and Evaluation of Triazolones as Checkpoint Kinase 1 Inhibitors
  617. 2yex: Synthesis and Evaluation of Triazolones as Checkpoint Kinase 1 Inhibitors
  618. 3uv4: Crystal Structure of The Second Bromodomain of Human Transcription Initiation Factor Tfiid Subunit 1 (taf1)
  619. 4daw: Crystal Structure of Pak1 Kinase Domain with The Ruthenium Phthalimide Complex
  620. 4dug: Crystal Structure of Circadian Clock Protein Kaic E318A Mutant
  621. 3vbq: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  622. 3vbt: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  623. 3vbv: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  624. 3vbw: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  625. 3vbx: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  626. 3vby: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  627. 3vc4: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  628. 2ydi: Discovery of Checkpoint Kinase Inhibitor Azd7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas
  629. 2ydk: Discovery of Checkpoint Kinase Inhibitor Azd7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas
  630. 3axw: Crystal Structure of Human CK2ALPHA Complexed with a Potent Inhibitor
  631. 3tkh: Crystal Structure of Chk1 in Complex with Inhibitor S01
  632. 3tki: Crystal Structure of Chk1 in Complex with Inhibitor S25
  633. 3uix: Crystal Structure of Pim1 Kinase in Complex with Small Molecule Inhibitor
  634. 4af3: Human Aurora B Kinase in Complex with Incenp and Vx-680
  635. 4aot: Crystal Structure of Human Serine Threonine Kinase-10 (lok) Bound to GW830263A
  636. 4d9u: Rsk2 C-terminal Kinase Domain, (e)-tert-butyl 3-(4-amino-7-(3- Hydroxypropyl)-5-p-tolyl-7h-pyrrolo[2,3-d]pyrimidin-6-yl)-2- Cyanoacrylate
  637. 4dbn: Crystal Structure of The Kinase Domain of Human B-raf with a [1, 3]thiazolo[5,4-b]pyridine Derivative
  638. 3rny: Crystal Structure of Human Rsk1 C-terminal Kinase Domain
  639. 4a4x: Nek2-ede Bound to Cct248662
  640. 4afe: Nek2 Bound to Hybrid Compound 21
  641. 4apc: Crystal Structure of Human Nima-related Kinase 1 (nek1)
  642. 4d9t: Rsk2 C-terminal Kinase Domain with Inhibitor (e)-methyl 3-(4-amino-7- (3-hydroxypropyl)-5-p-tolyl-7h-pyrrolo[2,3-d]pyrimidin-6-yl)-2- Cyanoacrylate
  643. 3re4: Crystal Structure of Archaeoglobus Fulgidus Rio1 Kinase Bound to Toyocamycin.
  644. 3vap: Synthesis and Sar Studies of Imidazo-[1,2-a]-pyrazine Aurora Kinase Inhibitors with Improved off Target Kinase Selectivity
  645. 4anu: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
  646. 4anv: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
  647. 4anw: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
  648. 4anx: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
  649. 4aof: Selective Small Molecule Inhibitor Discovered by Chemoproteomic Assay Platform Reveals Regulation of Th17 Cell Differentiation by PI3KGAMMA
  650. 4dgl: Crystal Structure of The Ck2 Tetrameric Holoenzyme
  651. 4e26: Braf in Complex with an Organic Inhibitor 7898734
  652. 4e4x: Crystal Structure of B-raf Kinase Domain in Complex with a Dihydropyrido[2,3-d]pyrimidinone-based Inhibitor
  653. 4acc: GSK3B in Complex with Inhibitor
  654. 4acd: GSK3B in Complex with Inhibitor
  655. 4acg: GSK3B in Complex with Inhibitor
  656. 4ach: GSK3B in Complex with Inhibitor
  657. 4dk5: Crystal Structure of Human PI3K-GAMMA in Complex with a Pyridyl- Triazine Inhibitor
  658. 4e7w: Structure of Gsk3 from Ustilago Maydis
  659. 4eep: Crystal Structure of Lov2 Domain of Arabidopsis Thaliana Phototropin 2
  660. 4eer: Crystal Structure of Lov2 Domain of Arabidopsis Thaliana Phototropin 2 C426A Mutant
  661. 4ees: Crystal Structure of Ilov
  662. 4eet: Crystal Structure of Ilov
  663. 4eeu: Crystal Structure of Philov2.1
  664. 2lru: Solution Structure of The Wnk1 Autoinhibitory Domain
  665. 3uim: Structural Basis for The Impact of Phosphorylation on Plant Receptor- like Kinase Bak1 Activation
  666. 4anm: Complex of Ck2 with a Cdc7 Inhibitor
  667. 4ejn: Crystal Structure of Autoinhibited Form of Akt1 in Complex with N-(4- (5-(3-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3h-imidazo[4,5- B]pyridin-3-yl)benzyl)-3-fluorobenzamide
  668. 4ekk: Akt1 with Amp-pnp
  669. 4ekl: Akt1 with Gdc0068
  670. 4eut: Structure of Bx-795 Complexed with Unphosphorylated Human Tbk1 Kinase- Uld Domain
  671. 4euu: Structure of Bx-795 Complexed with Human Tbk1 Kinase Domain Phosphorylated on Ser172
  672. 2rse: Nmr Structure of Fkbp12-mtor Frb Domain-rapamycin Complex Structure Determined Based on Pcs
  673. 3u87: Structure of a Chimeric Construct of Human CK2ALPHA and Human CK2ALPHA' in Complex with a Non-hydrolysable Atp-analogue
  674. 3u9c: Structure of a C-terminal Deletion Mutant of Human Protein Kinase Ck2 Catalytic Subunit with The Atp-competitive Inhibitor Resorufin
  675. 4eai: Co-crystal Structure of an Ampk Core with Amp
  676. 4eaj: Co-crystal of Ampk Core with Amp Soaked with Atp
  677. 4eak: Co-crystal Structure of an Ampk Core with Atp
  678. 4eal: Co-crystal of Ampk Core with Atp Soaked with Amp
  679. 4aw2: Crystal Structure of Cdc42 Binding Protein Kinase Alpha (mrck Alpha)
  680. 4efo: Crystal Structure of The Ubiquitin-like Domain of Human Tbk1
  681. 4f0f: Crystal Structure of The Roco4 Kinase Domain Bound to Appcp from D. Discoideum
  682. 4f0g: Crystal Structure of The Roco4 Kinase Domain from D. Discoideum
  683. 4f1m: Crystal Structure of The G1179S Roco4 Kinase Domain Bound to Appcp from D. Discoideum.
  684. 4f1t: Crystal Structure of The Roco4 Kinase Domain from D. Discoideum Bound to The Rock Inhibitor H1152
  685. 4dhf: Structure of Aurora a Mutant Bound to Biogenidec Cpd 15
  686. 4dtk: Novel and Selective Pan-pim Kinase Inhibitor
  687. 4fhj: Crystal Structure of PI3K-GAMMA in Complex with Imidazopyridine 2
  688. 4fr4: Crystal Structure of Human Serine/threonine-protein Kinase 32a (yank1)
  689. 3zxt: Dimeric Structure of Dapk-1 Catalytic Domain in Complex with Amppcp-mg
  690. 4dgm: Crystal Structure of Maize Ck2 in Complex with The Inhibitor Apigenin
  691. 4dgn: Crystal Structure of Maize Ck2 in Complex with The Inhibitor Luteolin
  692. 4dgo: Crystal Structure of Maize Ck2 in Complex with Tyrphostin Ag99
  693. 3umx: Crystal Structure of Pim1 Kinase in Complex with Inhibitor (z)-2-[(1h- Indol-3-yl)methylene]-7-(azepan-1-ylmethyl)-6-hydroxybenzofuran- 3(2h)-one
  694. 3uto: Twitchin Kinase Region from C.elegans (fn31-nl-kin-crd-ig26)
  695. 4enx: Crystal Structure of Pim-1 Kinase in Complex with Inhibitor (2e,5z)-2- (2-chlorophenylimino)-5-(4-hydroxy-3-nitrobenzylidene)thiazolidin-4- One
  696. 4eny: Crystal Structure of Pim-1 Kinase in Complex with (2e,5z)-2-(2- Chlorophenylimino)-5-(4-hydroxy-3-methoxybenzylidene)thiazolidin-4- One
  697. 4f1s: Crystal Structure of Human PI3K-GAMMA in Complex with a Pyridyl- Triazine-sulfonamide Inhibitor
  698. 4fk3: B-raf Kinase V600E Oncogenic Mutant in Complex with Plx3203
  699. 4g31: Crystal Structure of Gsk6414 Bound to Perk (r587-r1092, Delete A660- T867) at 2.28 a Resolution
  700. 4g34: Crystal Structure of Gsk6924 Bound to Perk (r587-r1092, Delete A660- T867) at 2.70 a Resolution
  701. 3tei: Crystal Structure of Human Erk2 Complexed with a Mapk Docking Peptide
  702. 3twj: Rho-associated Protein Kinase 1 (rock 1) in Complex with Rki1447
  703. 3u4u: Casein Kinase 2 in Complex with Az-inhibitor
  704. 4dea: Aurora a in Complex with Yl1-038-18
  705. 4deb: Aurora a in Complex with Rk2-17-01
  706. 4ded: Aurora a in Complex with Yl1-038-21
  707. 4dee: Aurora a in Complex with Adp
  708. 4fsm: Crystal Structure of The Chk1
  709. 4fsn: Crystal Structure of The Chk1
  710. 4fsq: Crystal Structure of The Chk1
  711. 4fsr: Crystal Structure of The Chk1
  712. 4fst: Crystal Structure of The Chk1
  713. 4fsu: Crystal Structure of The Chk1
  714. 4fsw: Crystal Structure of The Chk1
  715. 4fsy: Crystal Structure of The Chk1
  716. 4fsz: Crystal Structure of The Chk1
  717. 4ft0: Crystal Structure of The Chk1
  718. 4ft3: Crystal Structure of The Chk1
  719. 4ft5: Crystal Structure of The Chk1
  720. 4ft7: Crystal Structure of The Chk1
  721. 4ft9: Crystal Structure of The Chk1
  722. 4fta: Crystal Structure of The Chk1
  723. 4ftc: Crystal Structure of The Chk1
  724. 4fti: Crystal Structure of The Chk1
  725. 4ftj: Crystal Structure of The Chk1
  726. 4ftk: Crystal Structure of The Chk1
  727. 4ftl: Crystal Structure of The Chk1
  728. 4ftm: Crystal Structure of The Chk1
  729. 4ftn: Crystal Structure of The Chk1
  730. 4fto: Crystal Structure of The Chk1
  731. 4ftq: Crystal Structure of The Chk1
  732. 4ftr: Crystal Structure of The Chk1
  733. 4ftt: Crystal Structure of The Chk1
  734. 4ftu: Crystal Structure of The Chk1
  735. 4gb9: Potent and Highly Selective Benzimidazole Inhibitors of PI3K-DELTA
  736. 3ubd: Structure of N-terminal Domain of Rsk2 Kinase in Complex with Flavonoid Glycoside Sl0101
  737. 3uib: Map Kinase Lmampk10 from Leishmania Major in Complex with Sb203580
  738. 4aze: Human DYRK1A in Complex with Leucettine L41
  739. 4azf: Human Dyrk2 in Complex with Leucettine L41
  740. 4b9d: Crystal Structure of Human Nima-related Kinase 1 (nek1) with Inhibitor.
  741. 4el9: Structure of N-terminal Kinase Domain of Rsk2 with Afzelin
  742. 4ewh: Co-crystal Structure of Ack1 with Inhibitor
  743. 4fie: Full-length Human Pak4
  744. 4fif: Catalytic Domain of Human Pak4 with Rpkplvdp Peptide
  745. 4fig: Catalytic Domain of Human Pak4
  746. 4fih: Catalytic Domain of Human Pak4 with Qkftglprqw Peptide
  747. 4fii: Catalytic Domain of Human Pak4 with Rpkplvdp Peptide
  748. 4fij: Catalytic Domain of Human Pak4
  749. 4fj3: 14-3-3 Isoform Zeta in Complex with a Diphoyphorylated C-raf Peptide
  750. 4flh: Crystal Structure of Human PI3K-GAMMA in Complex with Amg511
  751. 3tpb: Structure of HIPA(S150A)
  752. 3tpd: Structure of Phipa, Monoclinic Form
  753. 3tpe: The Phipa P3121 Structure
  754. 3tpt: Structure of HIPA(D309Q) Bound to Adp
  755. 3tpv: Structure of Phipa Bound to Adp
  756. 3umw: Crystal Structure of Pim1 Kinase in Complex with Inhibitor (z)-2-[(1h- Indazol-3-yl)methylene]-6-methoxy-7-(piperazin-1-ylmethyl)benzofuran- 3(2h)-one
  757. 4a9r: Crystal Structure of Human Chk2 in Complex with Benzimidazole Carboxamide Inhibitor
  758. 4a9s: Crystal Structure of Human Chk2 in Complex with Benzimidazole Carboxamide Inhibitor
  759. 4a9t: Crystal Structure of Human Chk2 in Complex with Benzimidazole Carboxamide Inhibitor
  760. 4a9u: Crystal Structure of Human Chk2 in Complex with Benzimidazole Carboxamide Inhibitor
  761. 4as0: Cyclometalated Phthalimides as Protein Kinase Inhibitors
  762. 4aw0: Human Pdk1 Kinase Domain in Complex with Allosteric Compound Ps182 Bound to The Pif-pocket
  763. 4aw1: Human Pdk1 Kinase Domain in Complex with Allosteric Compound Ps210 Bound to The Pif-pocket
  764. 4bc6: Crystal Structure of Human Serine Threonine Kinase-10 Bound to Novel Bosutinib Isoform 1, Previously Thought to Be Bosutinib
  765. 4fbx: Complex Structure of Human Protein Kinase Ck2 Catalytic Subunit Crystallized in The Presence of a Bisubstrate Inhibitor
  766. 4ful: Pi3 Kinase Gamma Bound to a Pyrmidine Inhibitor
  767. 4gh2: Crystal Structure of The Chk1
  768. 4gw8: Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and Leucettine L41
  769. 4f99: Human Cdc7 Kinase in Complex with Dbf4 and Nucleotide
  770. 4f9a: Human Cdc7 Kinase in Complex with Dbf4 and Nucleotide
  771. 4f9b: Human Cdc7 Kinase in Complex with Dbf4 and Pha767491
  772. 4f9c: Human Cdc7 Kinase in Complex with Dbf4 and Xl413
  773. 4fjy: Crystal Structure of PI3K-GAMMA in Complex with Quinoline-indoline Inhibitor 24f
  774. 4fjz: Crystal Structure of PI3K-GAMMA in Complex with Pyrrolo-pyridine Inhibitor 63
  775. 4gyw: Crystal Structure of Human O-glcnac Transferase in Complex with Udp and a Glycopeptide
  776. 4gyy: Crystal Structure of Human O-glcnac Transferase with Udp-5sglcnac and a Peptide Substrate
  777. 4gz3: Crystal Structure of Human O-glcnac Transferase with Udp and a Thioglycopeptide
  778. 3uiu: Crystal Structure of Apo-pkr Kinase Domain
  779. 3ulz: Crystal Structure of Apo Bak1
  780. 4equ: Human Stk-10 (lok) Kinase Domain in Dfg-out Conformation with Inhibitor Dsa-7
  781. 4g11: X-ray Structure of PI3K-GAMMA Bound to a 4-(morpholin-4-yl)- (6-oxo-1, 6-dihydropyrimidin-2-yl)amide Inhibitor
  782. 4g9c: Human B-raf Kinase Domain Bound to a Type II Pyrazolopyridine Inhibitor
  783. 4g9r: B-raf V600E Kinase Domain Bound to a Type II Dihydroquinazoline Inhibitor
  784. 4ggd: Structural Analysis of Human Cdc20 Supports Multisite Degron Recognition by Apc/c.
  785. 4hgl: Crystal Structure of CK1G3 with Compound 1
  786. 4hgs: Crystal Structure of CK1GS with Compound 13
  787. 4hgt: Crystal Structure of CK1D with Compound 13
  788. 4hnf: Crystal Structure of CK1D in Complex with Pf4800567
  789. 4hni: Crystal Structure of CK1E in Complex with Pf4800567
  790. 4hok: Crystal Structure of Apo CK1E
  791. 3zdi: Glycogen Synthase Kinase 3 Beta Complexed with Axin Peptide and Inhibitor 7d
  792. 3zgw: Crystal Structure of Maternal Embryonic Leucine Zipper Kinase (melk) in Complex with Amp-pnp
  793. 3zhp: Human Mst3 (stk24) in Complex with MO25BETA
  794. 3zim: Discovery of a Potent and Isoform-selective Targeted Covalent Inhibitor of The Lipid Kinase PI3KALPHA
  795. 4alu: Benzofuropyrimidinone Inhibitors of Pim-1
  796. 4alv: Benzofuropyrimidinone Inhibitors of Pim-1
  797. 4b7t: Glycogen Synthase Kinase 3 Beta Complexed with Axin Peptide and Leucettine L4
  798. 4drh: Co-crystal Structure of The Ppiase Domain of Fkbp51, Rapamycin and The Frb Fragment of Mtor at Low Ph
  799. 4dri: Co-crystal Structure of The Ppiase Domain of Fkbp51, Rapamycin and The Frb Fragment of Mtor
  800. 4drj: O-crystal Structure of The Ppiase Domain of Fkbp52, Rapamycin and The Frb Fragment of Mtor
  801. 4gue: Structure of N-terminal Kinase Domain of Rsk2 with Flavonoid Glycoside Quercitrin
  802. 4gv1: Pkb Alpha in Complex with Azd5363
  803. 4h3p: Crystal Structure of Human Erk2 Complexed with a Mapk Docking Peptide
  804. 4h58: Braf in Complex with Compound 3
  805. 4hle: Compound 21 (1-alkyl-substituted 1,2,4-triazoles)
  806. 4hzr: Crystal Structure of Ack1 Kinase Domain
  807. 4hzs: Crystal Structure of Ack1 Kinase Domain with C-terminal Sh3 Domain
  808. 4id7: Ack1 Kinase in Complex with The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
  809. 4ijm: Crystal Structure of Circadian Clock Protein Kaic A422V Mutant
  810. 3zon: Human Tyk2 Pseudokinase Domain Bound to a Kinase Inhibitor
  811. 4b0g: Complex of Aurora-a Bound to an Imidazopyridine-based Inhibitor
  812. 4ezj: Potent and Selective Inhibitors of PI3K-DELTA: Obtaining Isoform Selectivity from The Affinity Pocket and Tryptophan Shelf
  813. 4ezk: Potent and Selective Inhibitors of PI3K-DELTA: Obtaining Isoform Selectivity from The Affinity Pocket and Tryptophan Shelf
  814. 4ezl: Potent and Selective Inhibitors of PI3K-DELTA: Obtaining Isoform Selectivity from The Affinity Pocket and Tryptophan Shelf
  815. 4fa6: Design and Synthesis of a Novel Pyrrolidinyl Pyrido Pyrimidinone Derivative as a Potent Inhibitor of PI3KA and Mtor
  816. 4fad: Design and Synthesis of a Novel Pyrrolidinyl Pyrido Pyrimidinone Derivative as a Potent Inhibitor of PI3KA and Mtor
  817. 4fhk: Crystal Structure of PI3K-GAMMA in Complex with Imidazopyridazine 19e
  818. 4fza: Crystal Structure of Mst4-mo25 Complex
  819. 4fzd: Crystal Structure of Mst4-mo25 Complex with Wsf Motif
  820. 4fzf: Crystal Structure of Mst4-mo25 Complex with Dki
  821. 4geh: Crystal Structure of Mst4 Dimerization Domain Complex with Pdcd10
  822. 4hyh: X-ray Crystal Structure of Compound 39 Bound to Human Chk1 Kinase Domain
  823. 4hyi: X-ray Crystal Structure of Compound 40 Bound to Human Chk1 Kinase Domain
  824. 4ib5: Structure of Human Protein Kinase Ck2 Catalytic Subunit in Complex with a CK2BETA-COMPETITIVE Cyclic Peptide
  825. 4im0: Structure of Tank-binding Kinase 1
  826. 4im2: Structure of Tank-binding Kinase 1
  827. 4im3: Structure of Tank-binding Kinase 1
  828. 4ith: Crystal Structure of Rip1 Kinase in Complex with Necrostatin-1 Analog
  829. 4iti: Crystal Structure of Rip1 Kinase in Complex with Necrostatin-3 Analog
  830. 4itj: Crystal Structure of Rip1 Kinase in Complex with Necrostatin-4
  831. 4iw0: Crystal Structure and Mechanism of Activation of Tbk1
  832. 4iwo: Crystal Structure and Mechanism of Activation of Tbk1
  833. 4iwp: Crystal Structure and Mechanism of Activation of Tbk1
  834. 4iwq: Crystal Structure and Mechanism of Activation of Tbk1
  835. 4j1r: Crystal Structure of GSK3B in Complex with Inhibitor 15r
  836. 4j71: Crystal Structure of GSK3B in Complex with Inhibitor 1r
  837. 4jg6: Rsk2 Ctd Bound to 2-cyano-3-(1h-indazol-5-yl)acrylamide
  838. 4jg7: Structure of Rsk2 Ctd Bound to 3-(3-(1h-pyrrolo[2,3-b]pyridine-3- Carbonyl)phenyl)-2-cyanoacrylamide
  839. 4jg8: Structure of Rsk2 T493M Ctd Mutant Bound to 2-cyano-n-(1-hydroxy-2- Methylpropan-2-yl)-3-(3-(3,4,5-trimethoxyphenyl)-1h-indazol-5-yl) Acrylamide
  840. 4jik: X-ray Crystal Structure of Compound 22a (r)-2-(4-chlorophenyl)-8- (piperidin-3-ylamino)imidazo[1,2-c]pyrimidine-5-carboxamide Bound to Human Chk1 Kinase Domain
  841. 4ehe: B-raf Kinase Domain in Complex with an Aminothienopyrimidine-based Inhibitor
  842. 4ehg: B-raf Kinase Domain in Complex with an Aminopyridimine-based Inhibitor
  843. 4iq6: Gsk-3beta with Inhibitor 6-chloro-n-cyclohexyl-4-(1h-pyrrolo[2,3- B]pyridin-3-yl)pyridin-2-amine
  844. 4jin: X-ray Crystal Structure of Archaeoglobus Fulgidus Rio1 Bound to (2e)- N-benzyl-2-cyano-3-(pyridine-4-yl)acrylamide (wp1086)
  845. 4bl1: Crystal Structure of Unphosphorylated Maternal Embryonic Leucine Zipper Kinase (melk) in Complex with Amp-pnp
  846. 4jsn: Structure of Mtordeltan-mlst8 Complex
  847. 4jsp: Structure of Mtordeltan-mlst8-atpgammas-mg Complex
  848. 4jsv: Structure of Mtordeltan-mlst8-adp-mgf3-mg2 Complex
  849. 4jsx: Structure of Mtordeltan-mlst8-torin2 Complex
  850. 4jt5: Mtordeltan-mlst8-pp242 Complex
  851. 4g16: Crystal Structure of CK1G3 with 2-[(4-{[3-(trifluoromethyl)pyridin2- Yl]oxy}phenyl)amino]-1h-benzimidazole-6-carbonitrile
  852. 4g17: Crystal Structure of CK1G3 with 2-[(4-tert-butylphenyl)amino]-1h- Benzimidazole-6-carbonitrile
  853. 4hq1: Crystal Structure of an Lrr Protein with Two Solenoids
  854. 4jai: Crystal Structure of Aurora Kinase a in Complex with N-{4-[(6-oxo-5,6- Dihydrobenzo[c][1,8]naphthyridin-1-yl)amino]phenyl}benzamide
  855. 4jaj: Crystal Structure of Aurora Kinase a in Complex with Benzo[c][1, 8]naphthyridin-6(5h)-one
  856. 4jbo: Novel Aurora Kinase Inhibitors Reveal Mechanisms of Hurp in Nucleation of Centrosomal and Kinetochore Microtubules
  857. 4jbp: Novel Aurora Kinase Inhibitors Reveal Mechanisms of Hurp in Nucleation of Centrosomal and Kinetochore Microtubules
  858. 4jbq: Novel Aurora Kinase Inhibitors Reveal Mechanisms of Hurp in Nucleation of Centrosomal and Kinetochore Microtubules
  859. 4jjr: A P21 Crystal Form of Mammalian Casein Kinase 1d with a Novel Dimer Interface.
  860. 4jvg: B-raf Kinase in Complex with Birb796
  861. 4k0y: Structure of Pim-1 Kinase Bound to N-(4-fluorophenyl)-7-hydroxy-5- (piperidin-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
  862. 4k18: Structure of Pim-1 Kinase Bound to 5-(4-cyanobenzyl)-n-(4- Fluorophenyl)-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carboxamide
  863. 4k1b: Structure of Pim-1 Kinase Bound to N-(5-(2-fluorophenyl)-1h-pyrrolo[2, 3-b]pyridin-3-yl)-5-((((3r,4r)-3-fluoropiperidin-4-yl)methyl)amino) Pyrazolo[1,5-a]pyrimidine-3-carboxamide
  864. 4fi1: Crystal Structure of Scck2 Alpha in Complex with Atp
  865. 4jl9: Crystal Structure of Mouse Tbk1 Bound to Bx795
  866. 4jlc: Crystal Structure of Mouse Tbk1 Bound to Su6668
  867. 4l0n: Crystal Structure of Stk3 (mst2) Sarah Domain
  868. 4bda: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  869. 4bdb: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  870. 4bdc: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  871. 4bdd: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  872. 4bde: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  873. 4bdf: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  874. 4bdg: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  875. 4bdh: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  876. 4bdi: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  877. 4bdj: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  878. 4bdk: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  879. 4f2l: Structure of a Regulatory Domain of Ampk
  880. 2m9x: Solution Nmr Structure of Microtubule-associated Serine/threonine- Protein Kinase 1 from Homo Sapiens, Northeast Structural Genomics Consortium (nesg) Target HR9151A
  881. 3w8h: Crystal Structure of Ccm3 in Complex with The C-terminal Regulatory Domain of Stk25
  882. 3w8i: Crystal Structure of Ccm3 in Complex with The C-terminal Regulatory Domain of Mst4
  883. 4b8l: Aurora B Kinase P353G Mutant
  884. 4b8m: Aurora B Kinase in Complex with Vx-680
  885. 4g0n: Crystal Structure of Wt H-ras-gppnhp Bound to The Rbd of Raf Kinase
  886. 4g3x: Crystal Structure of Q61L H-ras-gppnhp Bound to The Rbd of Raf Kinase
  887. 4kz0: Structure of PI3K Gamma with Imidazopyridine Inhibitors
  888. 4kzc: Structure of PI3K Gamma with Imidazopyridine Inhibitors
  889. 4j0m: Crystal Structure of Brl1 (lrr) in Complex with Brassinolide
  890. 4ksp: Crystal Structure of Human B-raf Bound to a Dfg-out Inhibitor Tak-632
  891. 4ksq: Crystal Structure of Human B-raf Bound to a Dfg-out Inhibitor 5b
  892. 2rsv: Solution Structure of Human Full-length Vaccinia Related Kinase 1 (vrk1)
  893. 3w10: Aurora Kinase a Complexed to Pyrazole Aminoquinoline I
  894. 3w16: Structure of Aurora Kinase a Complexed to Pyrazole-aminoquinoline Inhibitor III
  895. 3w18: Structure of Aurora Kinase a Complexed to Benzoimidazole-indazole Inhibitor XIII
  896. 3w2c: Structure of Aurora Kinase a Complexed to Benzoimidazole-indazole Inhibitor Xv
  897. 3w8l: Crystal Structure of Human Ck2 in Complex with Inositol Hexakisphosphate
  898. 3war: Crystal Structure of Human CK2A
  899. 3we4: Crystal Structure of S6K1 Kinase Domain in Complex with a Pyrimidine Derivative Pf-4708671 2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1- Yl]methyl}-5-(trifluoromethyl)-1h-benzimidazole
  900. 3we8: Pim-1 Kinase in Complex with Ruthenium-based Inhibitor
  901. 3wf5: Crystal Structure of S6K1 Kinase Domain in Complex with a Pyrazolopyrimidine Derivative 4-[4-(1h-benzimidazol-2-yl)piperidin-1- Yl]-1h-pyrazolo[3,4-d]pyrimidine
  902. 3wf6: Crystal Structure of S6K1 Kinase Domain in Complex with a Pyrazolopyrimidine Derivative 4-[4-(1h-indol-3-yl)-3,6- Dihydropyridin-1(2h)-yl]-1h-pyrazolo[3,4-d]pyrimidine
  903. 3wf7: Crystal Structure of S6K1 Kinase Domain in Complex with a Purine Derivative 1-(9h-purin-6-yl)-n-[3-(trifluoromethyl)phenyl]piperidine- 4-carboxamide
  904. 3wf8: Crystal Structure of S6K1 Kinase Domain in Complex with a Quinoline Derivative 2-oxo-2-[(4-sulfamoylphenyl)amino]ethyl 7,8,9,10- Tetrahydro-6h-cyclohepta[b]quinoline-11-carboxylate
  905. 3wf9: Crystal Structure of S6K1 Kinase Domain in Complex with a Quinoline Derivative 1-oxo-1-[(4-sulfamoylphenyl)amino]propan-2-yl-2-methyl-1, 2,3,4-tetrahydroacridine-9-carboxylate
  906. 3wi6: Crystal Structure of Mapkap Kinase-2 (mk2) in Complex with Non- Selective Inhibitor
  907. 3wik: Crystal Structure of The CK2ALPHA/COMPOUND10 Complex
  908. 3wil: Crystal Structure of The CK2ALPHA/COMPOUND3 Complex
  909. 4b4l: Crystal Structure of an Ard Dap-kinase 1 Mutant
  910. 4bfm: The Crystal Structure of Mouse Pk38
  911. 4bky: Crystal Structure of Unphosphorylated Maternal Embryonic Leucine Zipper Kinase (melk) in Complex with Pyrrolopyrazole Inhibitor
  912. 4bkz: Crystal Structure of Unphosphorylated Maternal Embryonic Leucine Zipper Kinase (melk) in Complex with a Benzodipyrazole Inhibitor
  913. 4bl0: Crystal Structure of Yeast Bub3-bub1 Bound to Phospho-spc105
  914. 4bn1: Crystal Structure of V174M Mutant of Aurora-a Kinase
  915. 4btj: Ttbk1 in Complex with Atp
  916. 4btk: Ttbk1 in Complex with Inhibitor
  917. 4btm: Ttbk1 in Complex with Inhibitor
  918. 4bxa: Tetragonal Complex Structure of Protein Kinase Ck2 Catalytic Subunit with a Benzotriazole-based Inhibitor Generated by Click-chemistry
  919. 4bxb: Monoclinic Complex Structure of Protein Kinase Ck2 Catalytic Subunit with a Benzotriazole-based Inhibitor Generated by Click-chemistry
  920. 4byi: Aurora a Kinase Bound to a Highly Selective Imidazopyridine Inhibitor
  921. 4byj: Aurora a Kinase Bound to a Highly Selective Imidazopyridine Inhibitor
  922. 4bzn: Crystal Structure of Pim1 in Complex with a Pyrrolo(1,2-a) Pyrazinone Inhibitor
  923. 4bzo: Crystal Structure of Pim1 in Complex with a Pyrrolo- Pyrazinone Inhibitor
  924. 4c0t: Candida Albicans Pkh Kinase Domain
  925. 4c2v: Aurora B Kinase in Complex with The Specific Inhibitor Barasertib
  926. 4c2w: Crystal Structure of Aurora B in Complex with Amp-pnp
  927. 4c3p: Structure of Dephosphorylated Aurora a (122-403) Bound to Tpx2 and Amppcp
  928. 4c3r: Structure of Dephosphorylated Aurora a (122-403) Bound to Amppcp
  929. 4c4k: Crystal Structure of The Titin M10-obscurin Ig Domain 1 Complex
  930. 4c57: Structure of Gak Kinase in Complex with a Nanobody
  931. 4c58: Structure of Gak Kinase in Complex with Nanobody (nbgak_4)
  932. 4c59: Structure of Gak Kinase in Complex with Nanobody (nbgak_4)
  933. 4c8b: Structure of The Kinase Domain of Human Ripk2 in Complex with Ponatinib
  934. 4cfe: Structure of Full Length Human Ampk in Complex with a Small Molecule Activator, a Benzimidazole Derivative (991)
  935. 4cff: Structure of Full Length Human Ampk in Complex with a Small Molecule Activator, a Thienopyridone Derivative (a-769662)
  936. 4cfh: Structure of an Active Form of Mammalian Ampk
  937. 4ch9: Crystal Structure of The Human Klhl3 Kelch Domain in Complex with a Wnk4 Peptide
  938. 4chb: Crystal Structure of The Human Klhl2 Kelch Domain in Complex with a Wnk4 Peptide
  939. 4cqg: The Crystal Structure of Mpk38 in Complex with Otssp167, an Orally-administrative Melk Selective Inhibitor
  940. 4ct1: Human Pdk1-pkczeta Kinase Chimera in Complex with Allosteric Compound Ps315 Bound to The Pif-pocket
  941. 4ct2: Human Pdk1-pkczeta Kinase Chimera
  942. 4czt: Crystal Structure of The Kinase Domain of Snrk3.23 AT1G30270
  943. 4czu: Crystal Structure of The Kinase Domain of Snrk3.23 AT1G30270 T190D Mutant
  944. 4d28: Crystal Structure of The Kinase Domain of Snrk3.11 AT5G35410
  945. 4d2p: Structure of Melk in Complex with Inhibitors
  946. 4d2t: Structure of Melk in Complex with Inhibitors
  947. 4d2v: Structure of Melk in Complex with Inhibitors
  948. 4d2w: Structure of Melk in Complex with Inhibitors
  949. 4eqc: Crystal Structure of Pak1 Kinase Domain in Complex with Frax597 Inhibitor
  950. 4fc0: Crystal Structure of Human Kinase Domain of B-raf with a Dfg-out Inhibitor
  951. 4grb: Casein Kinase 2 (ck2) Bound to Inhibitor
  952. 4gub: Casein Kinase II Bound to Inhibitor
  953. 4hhd: 2.75 Angstrom Resolution Crystal Structure of The A. Thaliana Lov2 Domain with an Extended N-terminal A' Helix (cryo Dark Structure)
  954. 4hi8: Structure of Integrin-linked Kinase Ankyrin Repeat Domain in Complex with Pinch1 Lim1 Domain Collected at High Energy, Wavelength 0.32800
  955. 4hi9: 1.2 Structure of Integrin-linked Kinase Ankyrin Repeat Domain in Complex with Pinch1 Lim1 Domain Collected at Wavelength 0.91974
  956. 4hkd: Crystal Structure of Human Mst2 Sarah Domain
  957. 4hvb: Catalytic Unit of PI3KG in Complex with PI3K/MTOR Dual Inhibitor Pf- 04979064
  958. 4i41: Crystal Structure of Human Ser/thr Kinase Pim1 in Complex with Mitoxantrone
  959. 4i92: Structure of The Bsk8 Kinase Domain
  960. 4i93: Structure of The Bsk8 Kinase Domain (semet Labeled)
  961. 4i94: Structure of Bsk8 in Complex with Amp-pnp
  962. 4iaa: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Thioridazine
  963. 4ian: Crystal Structure of Apo Human PRPF4B Kinase Domain
  964. 4iea: 14-3-3 Isoform Sigma in Complex with a Phosphorylated C-raf Peptide
  965. 4ifc: Crystal Structure of Adp-bound Human PRPF4B Kinase Domain
  966. 4ihl: Human 14-3-3 Isoform Zeta in Complex with a Diphoyphorylated C-raf Peptide and Cotylenin a
  967. 4iir: Crystal Structure of Amppnp-bound Human PRPF4B Kinase Domain
  968. 4ijp: Crystal Structure of Human PRPF4B Kinase Domain in Complex with 4-{5- [(2-chloro-pyridin-4-ylmethyl)-carbamoyl]-thiophen-2-yl}- Benzo[b]thiophene-2-carboxylic Acid Amine
  969. 4ixp: Crystal Structure of Maternal Embryonic Leucine Zipper Kinase (melk)
  970. 4j6i: Discovery of Thiazolobenzoxepin Pi3-kinase Inhibitors That Spare The Pi3-kinase Beta Isoform
  971. 4j8m: Aurora a in Complex with Cd532
  972. 4j8n: Aurora a Kinase Apo
  973. 4jdh: Crystal Structure of Serine/threonine-protein Kinase Pak 4 in Complex with Paktide T Peptide Substrate
  974. 4jdi: Crystal Structure of Serine/threonine-protein Kinase Pak 4 in Complex with Paktide S Peptide Substrate
  975. 4jdj: Crystal Structure of Serine/threonine-protein Kinase Pak 4 F461V Mutant in Complex with Paktide T Peptide Substrate
  976. 4jdk: Crystal Structure of Serine/threonine-protein Kinase Pak 4 F461V Mutant in Complex with Paktide S Peptide Substrate
  977. 4jnw: Bacterially Expressed Titin Kinase
  978. 4jps: Co-crystal Structures of The Lipid Kinase PI3K Alpha with Pan and Isoform Selective Inhibitors
  979. 4jqe: Crystal Structure of Scck2 Alpha in Complex with Amppn
  980. 4jr7: Crystal Structure of Scck2 Alpha in Complex with Gmppnp
  981. 4jx3: Crystal Structure of Pim1 Kinase
  982. 4jx7: Crystal Structure of Pim1 Kinase in Complex with Inhibitor 2-[(trans- 4-aminocyclohexyl)amino]-4-{[3-(trifluoromethyl) Phenyl]amino}pyrido[4,3-d]pyrimidin-5(6h)-one
  983. 4kb8: CK1D in Complex with 1-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4- Yl]pyridin-2-yl}-n-methylmethanamine Ligand
  984. 4kba: CK1D in Complex with 9-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]- 2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine Inhibitor
  985. 4kbc: CK1D in Complex with {4-[3-(4-fluorophenyl)-1h-pyrazol-4-yl]pyridin-2- Yl}methanol Inhibitor
  986. 4kbk: CK1D in Complex with (3s)-3-{4-[3-(4-fluorophenyl)-1-methyl-1h- Pyrazol-4-yl]pyridin-2-yl}morpholine Inhibitor
  987. 4ks7: Pak6 Kinase Domain in Complex with Pf-3758309
  988. 4ks8: Pak6 Kinase Domain in Complex with Sunitinib
  989. 4kwp: Crystal Structure of Human Ck2-alpha in Complex with a Benzimidazole Inhibitor (k164) at 1.25 a Resolution
  990. 4l1b: Crystal Structure of P110ALPHA Complexed with Nish2 of P85ALPHA
  991. 4l23: Crystal Structure of P110ALPHA Complexed with Nish2 of P85ALPHA and Pi-103
  992. 4l2y: Crystal Structure of P110ALPHA Complexed with Nish2 of P85ALPHA and Compound 9d
  993. 4l67: Crystal Structure of Catalytic Domain of Pak4
  994. 4l6q: Rock2 in Complex with Benzoxaborole
  995. 4lb5: Crystal Structure of Pkz Zalpha in Complex with Ds(cg)6 (hexagonal Form)
  996. 4lb6: Crystal Structure of Pkz Zalpha in Complex with Ds(cg)6 (tetragonal Form)
  997. 4lfi: Crystal Structure of Scck2 Alpha in Complex with Gmppnp
  998. 4lg4: Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by Rassf5
  999. 4lgd: Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by Rassf5
  1000. 4ll5: Crystal Structure of Pim-1 in Complex with The Fluorescent Compound Skf86002
  1001. 4lm5: Crystal Structure of Pim1 in Complex with 2-{4-[(3-aminopropyl) Amino]quinazolin-2-yl}phenol (resulting from Displacement of Skf86002)
  1002. 4lmu: Crystal Structure of Pim1 in Complex with The Inhibitor Quercetin (resulting from Displacement of Skf86002)
  1003. 4lqp: Crystal Structure of The CBK1(T743E)-MOB2 Kinase-coactivator Complex, in Crystal Form a
  1004. 4lqq: Crystal Structure of The CBK1(T743E)-MOB2 Kinase-coactivator Complex in Crystal Form B
  1005. 4lqs: Crystal Structure of The Cbk1-mob2 Kinase-coactivator Complex
  1006. 4lrj: Bacterial Effector Nleh1 Kinase Domain with Amppnp and Mg2+
  1007. 4lrk: Bacterial Effector Nleh2 Kinase Domain
  1008. 4m66: Crystal Structure of The Mouse Rip3 Kinase Domain
  1009. 4m69: Crystal Structure of The Mouse Rip3-mlkl Complex
  1010. 4m7e: Structural Insight into Bl-induced Activation of The Bri1-bak1 Complex
  1011. 4m7i: Crystal Structure of Gsk6157 Bound to Perk (r587-r1092, Delete A660- T867) at 2.34a Resolution
  1012. 4m8t: Rsk2 T493M C-terminal Kinase Domain in Complex with 3-(3-(1h-pyrazol- 4-yl)phenyl)-2-cyanoacrylamide
  1013. 4mao: Rsk2 T493M C-terminal Kinase Domain in Complex with Rmm58
  1014. 4mbi: Discovery of Pyrazolo[1,5a]pyrimidine-based Pim1 Inhibitors
  1015. 4mbj: Human B-raf Kinase Domain in Complex with an Imidazopyridine-based Inhibitor
  1016. 4mbl: Discovery of Pyrazolo[1,5a]pyrimidine-based Pim1 Inhibitors
  1017. 4md7: Crystal Structure of Full-length Symmetric Ck2 Holoenzyme
  1018. 4md8: Crystal Structure of Full-length Symmetric Ck2 Holoenzyme with Mutated Alpha Subunit (F121E)
  1019. 4md9: Crystal Structure of Symmetric Ck2 Holoenzyme with Mutated Alpha Subunit (F121E Truncated at Aa 336)
  1020. 4med: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Thioridazine Derivatives
  1021. 4mn8: Crystal Structure of Flg22 in Complex with The Fls2 and Bak1 Ectodomains
  1022. 4mna: Crystal Structure of The Free Fls2 Ectodomains
  1023. 4mne: Crystal Structure of The Braf:mek1 Complex
  1024. 4mnf: Crystal Structure of BRAF-V600E Bound to Gdc0879
  1025. 4mvf: Crystal Structure of Plasmodium Falciparum Cdpk2 Complexed with Inhibitor Staurosporine
  1026. 4mwh: Crystal Structure of Scck2 Alpha in Complex with Atp
  1027. 4n6y: Pim1 Complexed with a Phenylcarboxamide
  1028. 4n6z: Pim1 Complexed with a Pyridylcarboxamide
  1029. 4n70: Pim1 Complexed with a Pyridylcarboxamide
  1030. 4neu: X-ray Structure of Receptor Interacting Protein 1 (rip1)kinase Domain with a 1-aminoisoquinoline Inhibitor
  1031. 4nfm: Human Tau Tubulin Kinase 1 (ttbk1)
  1032. 4nfn: Human Tau Tubulin Kinase 1 (ttbk1) Complexed with 3-({5-[(4-amino-4- Methylpiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)- 5-bromophenol
  1033. 4nh1: Crystal Structure of a Heterotetrameric Ck2 Holoenzyme Complex Carrying The Andante-mutation in CK2BETA and Consistent with Proposed Models of Autoinhibition and Trans-autophosphorylation
  1034. 4nif: Heterodimeric Structure of Erk2 and Rsk1
  1035. 4njd: Structure of P21-activated Kinase 4 with a Novel Inhibitor Ky-04031
  1036. 4nkb: Crystal Structure of The Cryptic Polo Box (cpb)of Zyg-1
  1037. 4nm0: Crystal Structure of Peptide Inhibitor-free Gsk-3/axin Complex
  1038. 4nm3: Crystal Structure of Gsk-3/axin Complex Bound to Phosphorylated N- Terminal Auto-inhibitory Ps9 Peptide
  1039. 4nr2: Crystal Structure of Stk4 (mst1) Sarah Domain
  1040. 4nu1: Crystal Structure of a Transition State Mimic of The Gsk-3/axin Complex Bound to Phosphorylated N-terminal Auto-inhibitory Ps9 Peptide
  1041. 4nus: Rsk2 N-terminal Kinase in Complex with Ljh685
  1042. 4nw5: Rsk2 N-terminal Kinase in Complex with 2-amino-7-substituted Benzoxazole Compound 8
  1043. 4nw6: Rsk2 N-terminal Kinase in Complex with 2-amino-7-substituted Benzoxazole Compound 27
  1044. 4nxb: Crystal Structure of Ilov-i486(2lt) at Ph 7.0
  1045. 4nxe: Crystal Structure of Ilov-i486(2lt) at Ph 6.5
  1046. 4nxf: Crystal Structure of Ilov-i486(2lt) at Ph 8.0
  1047. 4nxg: Crystal Structure of ILOV-I486Z(2LT) at Ph 9.0
  1048. 4o0m: Crystal Structure of T. Elongatus Bp-1 Clock Protein Kaic
  1049. 4o0r: Back Pocket Flexibility Provides Group-ii Pak Selectivity for Type 1 Kinase Inhibitors
  1050. 4o0t: Back Pocket Flexibility Provides Group-ii Pak Selectivity for Type 1 Kinase Inhibitors
  1051. 4o0v: Back Pocket Flexibility Provides Group-ii Pak Selectivity for Type 1 Kinase Inhibitors
  1052. 4o0x: Back Pocket Flexibility Provides Group-ii Pak Selectivity for Type 1 Kinase Inhibitors
  1053. 4o0y: Back Pocket Flexibility Provides Group-ii Pak Selectivity for Type 1 Kinase Inhibitors
  1054. 4o38: Crystal Structure of The Human Cyclin G Associated Kinase (gak)
  1055. 4oa2: Crystal Structure of The Bri1 Kinase Domain (865-1196) in Complex with Adp from Arabidopsis Thaliana
  1056. 4oa6: Crystal Structure of The Apo-bri1 Kinase Domain (865-1160)
  1057. 4oa9: Crystal Structure of The Bri1 Kinase Domain (865-1160) in Complex with Amppnp and Mn from Arabidopsis Thaliana
  1058. 4oab: Crystal Structure of The Bri1 Kinase Domain (865-1160) in Complex with Atp from Arabidopsis Thaliana
  1059. 4oac: Crystal Structure of The Bri1 Kinase Domain (865-1160) in Complex with Adp from Arabidopsis Thaliana
  1060. 4obo: MAP4K4 in Complex with Inhibitor (compound 22), 6-(3-chlorophenyl) Quinazolin-4-amine
  1061. 4obp: MAP4K4 in Complex with Inhibitor (compound 29), 6-(2-fluoropyridin-4- Yl)pyrido[3,2-d]pyrimidin-4-amine
  1062. 4obq: MAP4K4 in Complex with Inhibitor (compound 31), N-[3-(4- Aminoquinazolin-6-yl)-5-fluorophenyl]-2-(pyrrolidin-1-yl)acetamide
  1063. 4oh4: Crystal Structure of Bri1 in Complex with Bki1
  1064. 4oh8: Crystal Structure of The Human Mst1-rassf5 Sarah Heterodimer
  1065. 4oh9: Crystal Structure of The Human Mst2 Sarah Homodimer
  1066. 4otm: Crystal Structure of The C-terminal Domain from Yeast Gcn2
  1067. 4otn: Crystal Structure of The C-terminal Regulatory Domain of Murine Gcn2
  1068. 4otp: Crystal Structure of The Catalytic Domain of The Human Riok1 Atypical Protein Kinase in Complex with Adp/mg2+
  1069. 4ouc: Structure of Human Haspin in Complex with Histone H3 Substrate
  1070. 4p7i: Crystal Structure of The Merlin Ferm/dcaf1 Complex
  1071. 4p90: Crystal Structure of The Kinase Domain of Human Pak1 in Complex with Compound 15
  1072. 4pf4: 1.1a X-ray Structure of The Apo Catalytic Domain of Death-associated Protein Kinase 1, Aa 1-277
  1073. 4pl3: Crystal Structure of Murine Ire1 in Complex with Mkc9989 Inhibitor
  1074. 4pl4: Crystal Structure of Murine Ire1 in Complex with Oicr464 Inhibitor
  1075. 4pl5: Crystal Structure of Murine Ire1 in Complex with Oicr573 Inhibitor
  1076. 4pp7: Highly Potent and Selective 3-n-methylquinazoline-4(3h)-one Based Inhibitors of B-RAFV600E Kinase
  1077. 4prj: Aurora a Kinase Domain with Compound 2 (n-[1-(3-cyanobenzyl)-1h- Pyrazol-4-yl]-6-(1h-pyrazol-4-yl)-1h-indazole-3-carboxamide)
  1078. 4ps3: Structure of PI3K Gamma in Complex with 1-[6-(5-methoxypyridin-3-yl)- 1,3-benzothiazol-2-yl]-3-[2-(1-propyl-1h-imidazol-4-yl)ethyl]urea
  1079. 4ps7: Structure of PI3K Gamma in Complex with N-[6-(pyridin-3-yl)-1,3- Benzothiazol-2-yl]acetamide
  1080. 4ps8: Structure of PI3K Gamma in Complex with N-[6-(5,6-dimethoxypyridin-3- Yl)-1,3-benzothiazol-2-yl]acetamide
  1081. 4pwn: Crystal Structure of Active Wnk1 Kinase
  1082. 4pxw: Crystal Structure of Human Dcaf1 Wd40 Repeats (Q1250L)
  1083. 4q2a: Wnk1: a Chloride Sensor via Autophosphorylation
  1084. 4q5j: Crystal Structure of Semet Derivative Bri1 in Complex with Bki1
  1085. 4qfg: Structure of Ampk in Complex with Staurosporine Inhibitor and in The Absence of a Synthetic Activator
  1086. 4qfr: Structure of Ampk in Complex with Cl-a769662 Activator and Staurosporine Inhibitor
  1087. 4qfs: Structure of Ampk in Complex with BR2-A769662CORE Activator and Staurosporine Inhibitor
  1088. 4qox: Crystal Structure of Cdpk4 from Plasmodium Falciparum, PF3D7_0717500
  1089. 4qpm: Structure of Bub1 Kinase Domain
  1090. 4qtc: Structure of Human Haspin (gsg2) in Complex with Sch772984 Revealing The First Type-i Binding Mode
  1091. 4r8q: Structure and Substrate Recruitment of The Human Spindle Checkpoint Kinase Bub1
  1092. 4rgj: Apo Crystal Structure of Cdpk4 from Plasmodium Falciparum, PF3D7_0717500
  1093. 4tpt: Crystal Structure of The Human Limk2 Kinase Domain in Complex with a Non-atp Competitive Inhibitor
  1094. 4tuu: Isolated P110A Subunit of PI3KA Provides a Platform for Structure- Based Drug Design
  1095. 4tv3: Isolated P110A Subunit of PI3KA Provides a Platform for Structure- Based Drug Design
  1096. 4tw9: Difluoro-dioxolo-benzoimidazol-benzamides as Potent Inhibitors of CK1DELTA and Epsilon with Nanomolar Inhibitory Activity on Cancer Cell Proliferation
  1097. 4twc: 2-benzamido-n-(1h-benzo[d]imidazol-2-yl)thiazole-4- Carboxamide Derivatives as Potent Inhibitors of CK1D/E
  1098. 4txc: Crystal Structure of Dapk1 Kinase Domain in Complex with a Small Molecule Inhibitor
  1099. 4u43: MAP4K4 in Complex with Inhibitor (compound 6)
  1100. 4u44: MAP4K4 in Complex with Inhibitor (compound 16)
  1101. 4u45: MAP4K4 in Complex with Inhibitor (compound 25)
  1102. 4u6r: Crystal Structure of Human Ire1 Cytoplasmic Domains in Complex with a Sulfonamide Inhibitor.
  1103. 4u97: Crystal Structure of Asymmetric Irak4 Dimer
  1104. 4u9a: Sulphur Anomalous Crystal Structure of Asymmetric Irak4 Dimer
  1105. 4uak: Mrck Beta in Complex with Adp
  1106. 4ual: Mrck Beta in Complex with Bdp00005290
  1107. 4ump: Structure of Melk in Complex with Inhibitors
  1108. 4umq: Structure of Melk in Complex with Inhibitors
  1109. 4umr: Structure of Melk in Complex with Inhibitors
  1110. 4umt: Structure of Melk in Complex with Inhibitors
  1111. 4umu: Structure of Melk in Complex with Inhibitors
  1112. 4urk: PI3KG in Complex with Azd6482
  1113. 4uyn: Sar156497 an Exquisitely Selective Inhibitor of Aurora Kinases
  1114. 4uzd: Sar156497 an Exquisitely Selective Inhibitor of Aurora Kinases
  1115. 4uzh: Sar156497 an Exquisitely Selective Inhibitor of Aurora Kinases
  1116. 4w7p: Crystal Structure of Rock 1 Bound to Yb-15-qd37
  1117. 4w9w: Crystal Structure of Bmp-2-inducible Kinase in Complex with Small Molecule Azd-7762
  1118. 4w9x: Crystal Structure of Bmp-2-inducible Kinase in Complex with Baricitinib
  1119. 4wsq: Crystal Structure of Adaptor Protein 2 Associated Kinase (aak1) in Complex with Small Molecule Inhibitor
  1120. 4nzw: Crystal Structure of Stk25-mo25 Complex
  1121. 4o27: Crystal Structure of Mst3-mo25 Complex with wif Motif
  1122. 4rgw: Crystal Structure of a Taf1-taf7 Complex in Human Transcription Factor Iid
  1123. 4wo5: Crystal Structure of a Braf Kinase Domain Monomer
  1124. 4o0s: Crystal Structures of Human Kinase Aurora a
  1125. 4o0u: Crystal Structures of Human Kinase Aurora a
  1126. 4o0w: Crystal Structures of Human Kinase Aurora a
  1127. 4qye: Chk1 Kinase Domain in Complex with Diarylpyrazine Compound 1
  1128. 4qyf: Chk1 Kinase Domain in Complex with Aminopyrazine Compound 13
  1129. 4qyg: Chk1 Kinase Domain in Complex with Diazacarbazole Compound 14
  1130. 4qyh: Chk1 Kinase Domain in Complex with Diazacarbazole Gne-783
  1131. 4red: Crystal Structure of Human Ampk Alpha1 Kd-aid with K43A Mutation
  1132. 4rer: Crystal Structure of The Phosphorylated Human Alpha1 Beta2 Gamma1 Holo-ampk Complex Bound to Amp and Cyclodextrin
  1133. 4rew: Crystal Structure of The Non-phosphorylated Human Alpha1 Beta2 Gamma1 Holo-ampk Complex
  1134. 4rlk: Crystal Structure of Z. Mays CK2ALPHA in Complex with The Atp- Competitive Inhibitor 4-[(e)-(fluoren-9-ylidenehydrazinylidene)- Methyl] Benzoate
  1135. 4rll: Crystal Structure of Human CK2ALPHA in Complex with The Atp- Competitive Inhibitor 4-[(e)-(fluoren-9-ylidenehydrazinylidene)- Methyl] Benzoate
  1136. 4rqk: Crystal Structure of Pdk1 in Complex with Atp and The Pif-pocket Ligand Rs1
  1137. 4rqv: Crystal Structure of Pdk1 in Complex with Atp and The Pif-pocket Ligand Rs2
  1138. 4rrv: Crystal Structure of Pdk1 in Complex with Atp and Piftide
  1139. 4uow: Crystal Structure of The Titin M10-obscurin Ig Domain 1 Complex
  1140. 4wwn: Crystal Structure of Human PI3K-GAMMA in Complex with (s)-n-(1-(7- Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine Amg319 Inhibitor
  1141. 4wwo: Crystal Structure of Human PI3K-GAMMA in Complex with Phenylquinoline Inhibitor N-{(1s)-1-[8-chloro-2-(3-fluorophenyl)quinolin-3-yl]ethyl}- 9h-purin-6-amine
  1142. 4wwp: Crystal Structure of Human PI3K-GAMMA in Complex with Pyridinylquinoline Inhibitor N-{(1s)-1-[8-chloro-2-(2-methylpyridin- 3-yl)quinolin-3-yl]ethyl}-9h-purin-6-amine
  1143. 4o00: Crystal Structure of The Titin A-band Domain A3
  1144. 3wow: Crystal Structure of Human CK2A with Amppnp
  1145. 4mta: Crystal Structure of Pim-1 Kinase Domain in Complex with 2-methyl-5- Phenylfuran-3-carboxylic Acid
  1146. 4ow8: Crystal Structure of Kinase Domain of Pkna from Mtb
  1147. 4rlo: Human P70S6K1 with Ruthenium-based Inhibitor Em5
  1148. 4rlp: Human P70S6K1 with Ruthenium-based Inhibitor Fl772
  1149. 4rpv: Co-crystal Structure of Pim1 with Compound 3
  1150. 4ty1: Crystal Structure of Human Pim-1 Kinase in Complex with an Aminooxadiazole-indole Inhibitor.
  1151. 4waf: Crystal Structure of a Novel Tetrahydropyrazolo[1,5-a]pyrazine in an Engineered PI3K Alpha
  1152. 4wno: Structure of Ulk1 Bound to an Inhibitor
  1153. 4wnp: Structure of Ulk1 Bound to a Potent Inhibitor
  1154. 4wrs: Crystal Structure of Human Pim-1 Kinase in Complex with an Azaspiro Pyrazinyl-indazole Inhibitor.
  1155. 4wsy: Crystal Structure of Human Pim-1 Kinase in Complex with a Thiazolamine-indazole Inhibitor.
  1156. 4wt6: Crystal Structure of Human Pim-1 Kinase in Complex with a Thiadiazolamine-indole Inhibitor.
  1157. 4x3f: Crystal Structure of The Intracellular Domain of The M. Tuberculosis Ser/thr Kinase Pkna
  1158. 4x7h: Co-crystal Structure of Perk Bound to N-{5-[(6,7-dimethoxyquinolin-4- Yl)oxy]pyridin-2-yl}-1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3- Dihydro-1h-pyrazole-4-carboxamide Inhibitor
  1159. 4x7j: Co-crystal Structure of Perk with 2-amino-n-[4-methoxy-3- (trifluoromethyl)phenyl]-4-methyl-3-[2-(methylamino)quinazolin-6- Yl]benzamide Inhibitor
  1160. 4x7k: Co-crystal Structure of Perk Bound to 4-{2-amino-3-[5-fluoro-2- (methylamino)quinazolin-6-yl]-4-methylbenzoyl}-1-methyl-2,5-diphenyl- 1,2-dihydro-3h-pyrazol-3-one Inhibitor
  1161. 4x7l: Co-crystal Structure of Perk Bound to 4-{2-amino-4-methyl-3-[2- (methylamino)-1,3-benzothiazol-6-yl]benzoyl}-1-methyl-2,5-diphenyl-1, 2-dihydro-3h-pyrazol-3-one Inhibitor
  1162. 4x7n: Co-crystal Structure of Perk Bound to 4-[2-amino-4-methyl-3-(2- Methylquinolin-6-yl)benzoyl]-1-methyl-2,5-diphenyl-1,2-dihydro-3h- Pyrazol-3-one Inhibitor
  1163. 4x7o: Co-crystal Structure of Perk Bound to 1-[5-(4-amino-2,7-dimethyl-7h- Pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1h-indol-1-yl]-2-[3-fluoro- 5-(trifluoromethyl)phenyl]ethanone Inhibitor
  1164. 4x7q: Pim2 Kinase in Complex with Compound 1s
  1165. 4xhk: Pim1 Kinase in Complex with Compound 1s
  1166. 5aik: Human DYRK1A in Complex with Ldn-211898
  1167. 5ajq: Human Lok (stk10) in Complex with Bosutinib
  1168. 4rbl: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Mitoxantrone Derivatives
  1169. 4rc2: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Mitoxantrone Derivatives
  1170. 4rc3: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Mitoxantrone Derivatives
  1171. 4rc4: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Mitoxantrone Derivatives
  1172. 4u8z: Crystal Structure of Mst3 with a Pyrrolopyrimidine Inhibitor (pf- 06447475)
  1173. 4w8d: Crystal Structure of Mst3 with a Pyrrolopyrimidine Inhibitor (pf- 06454589).
  1174. 4w8e: Structure of Mst3 with a Pyrrolopyrimidine Inhibitor (pf-06645342)
  1175. 4ww5: Crystal Structure of Binary Complex Bud32-cgi121 in Complex with Ampp
  1176. 4ww7: Crystal Structure of Binary Complex Bud32-cgi121 in Complex with Amp
  1177. 4ww9: Crystal Structure of Binary Complex Bud32-cgi121 in Complex with Adp
  1178. 4wwa: Crystal Structure of Binary Complex Bud32-cgi121
  1179. 5air: Structural Analysis of Mouse GSK3BETA Fused with Lrp6 Peptide.
  1180. 4ptc: Structure of a Carboxamide Compound (3) (2-{2-[(cyclopropylcarbonyl) Amino]pyridin-4-yl}-4-oxo-4h-1lambda~4~,3-thiazole-5-carboxamide) to GSK3B
  1181. 4pte: Structure of a Carvoxamide Compound (15) (n-[4-(isoquinolin-7-yl) Pyridin-2-yl]cyclopropanecarboxamide) to GSK3B
  1182. 4ptg: Structure of a Carboxamine Compound (26) (2-{2-[(cyclopropylcarbonyl) Amino]pyridin-4-yl}-4-methoxypyrimidine-5-carboxamide) to GSK3B
  1183. 4y8d: Crystal Structure of Cyclin-g Associated Kinase (gak) Complexed with Selective 12i Inhibitor
  1184. 4rvt: MAP4K4 in Complex with a Pyridin-2(1h)-one Derivative
  1185. 4wot: Rock2 in Complex with 1426382-07-1
  1186. 4xs2: Irak4-inhibitor Co-structure
  1187. 4y0x: Crystal Structure of The S/t Protein Kinase Pkng from Mycobacterium Tuberculosis in Complex with Adp
  1188. 4y12: Crystal Structure of The S/t Protein Kinase Pkng from Mycobacterium Tuberculosis in Complex with Ags
  1189. 4y73: Crystal Structure of Irak4 Kinase Domain with Inhibitor
  1190. 4yo4: Crystal Structure of Dapk1 Catalytic Domain in Complex with The Hinge Binding Fragment Phthalazine
  1191. 4yo6: Irak4-inhibitor Co-structure
  1192. 4yp8: Irak4-inhibitor Co-structure
  1193. 4ypd: Crystal Structure of Dapk1 Catalytic Domain in Complex with The Hinge Binding Fragment 4-methylpyridazine
  1194. 4yzm: Humanized Roco4 Bound to Lrrk2-in1
  1195. 4yzn: Humanized Roco4 Bound to Compound 19
  1196. 4yzs: Crystal Structures Reveal Transient Perk Luminal Domain Tetramerization in Er Stress Signaling
  1197. 4yzy: Crystal Structures Reveal Transient Perk Luminal Domain Tetramerization in Er Stress Signaling
  1198. 4z7g: Crystal Structure of Human Ire1 Cytoplasmic Kinase-rnase Region - Apo
  1199. 4z7h: Crystal Structure of Human Ire1 Cytoplasmic Kinase-rnase Region - Complex with Imidazopyridine Compound 3
  1200. 5aja: Crystal Structure of Mandrill Samhd1 (amino Acid Residues 1-114) Bound to Vpx Isolated from Mandrill and Human Dcaf1 (amino Acid Residues 1058-1396)
© Copyright 2008-2009 by enzymes.me.uk